patient_id	feature_string	almanac_bin	phial_bin	sum	cohort	sensitive_predictive_implication	resistance_predictive_implication	prognostic_predictive_implication	clinvar	feature_type	feature_str_simple
MEL-IPI_Pat04	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat07	CDKN2A/B.Deletion	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat100	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat106	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat119	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat128	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat129	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat130	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat138	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat14	CDKN2A/B.Deletion	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat140	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat151	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat157	CDKN2A/B.Deletion	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat162	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat163	CDKN2A/B.Deletion	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat165	CDKN2A/B.Deletion	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat166	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat168	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat175	CDKN2A/B.Deletion	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat24	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat28	CDKN2A/B.Deletion	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat29	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat36	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat40	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat44	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat46	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat50	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat55	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat62	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat64	CDKN2A/B.Deletion	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat66	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat67	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat70	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat76	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat80	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat82	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat86	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat90	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat98	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	CDKN2A/B Del
MO_1014	CDKN2A/B.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	CDKN2A/B Del
MO_1094	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical				Somatic copy number	CDKN2A/B Del
PROS10448-1115157	CDKN2A/B.Deletion	Putatively Actionable		1	SU2C	Preclinical				Somatic copy number	CDKN2A/B Del
SC_9039	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical				Somatic copy number	CDKN2A/B Del
SC_9054	CDKN2A/B.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical				Somatic copy number	CDKN2A/B Del
MEL-IPI_Pat02	BLM.Amplification	Biologically Relevant		1	MEL					Somatic copy number	BLM Amp
MEL-IPI_Pat02	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat02	COL1A1--CITED4	Investigate Actionability		1	MEL	Guideline				Rearrangement	COL1A1--CITED4
MEL-IPI_Pat02	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat02	CTNNB1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	CTNNB1 Amp
MEL-IPI_Pat02	ERRFI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ERRFI1 Del
MEL-IPI_Pat02	EWSR1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	EWSR1 Amp
MEL-IPI_Pat02	JAK1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK1 Del
MEL-IPI_Pat02	MSH2.p.D887N	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat02	NTRK2.p.H300Y	Biologically Relevant		1	MEL					Somatic variant	NTRK2
MEL-IPI_Pat02	PDGFRB.p.G674E	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	PDGFRB
MEL-IPI_Pat02	STAG2.p.F467I	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat02	TSC2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	TSC2 Del
MEL-IPI_Pat02	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat02	ZRSR2.p.N261I	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	ZRSR2
MEL-IPI_Pat03	AKT3.p.P449S	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	AKT3
MEL-IPI_Pat03	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat03	BRCA2.p.E38K	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat03	COL1A1--MALAT1	Investigate Actionability		1	MEL	Guideline				Rearrangement	COL1A1--MALAT1
MEL-IPI_Pat03	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat03	EML4.Deletion	Biologically Relevant		1	MEL					Somatic copy number	EML4 Del
MEL-IPI_Pat03	FRMD8--EGFR	Biologically Relevant		1	MEL					Rearrangement	FRMD8--EGFR
MEL-IPI_Pat03	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat03	JAK1.p.P209S	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat03	MITF.p.T254MSplice_Site		Biologically Relevant	1	MEL					Somatic variant	MITF
MEL-IPI_Pat03	MSH6.p.G1216RSplice_Site	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat03	STAG2.p.K372KSplice_Site	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat03	TSC1.p.E801K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat03	TSC2.p.V118I	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat03	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat04	APC.p.R2204*		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat04	ATM.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ATM Del
MEL-IPI_Pat04	ATR.p.R861G		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat04	CHEK1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK1 Del
MEL-IPI_Pat04	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat04	EPHA3.p.C3Y		Biologically Relevant	1	MEL					Somatic variant	EPHA3
MEL-IPI_Pat04	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat04	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat04	JAK1.p.R110SSplice_Site	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat04	JAK2.p.R138Q	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	JAK2
MEL-IPI_Pat04	MITF.p.A283S		Biologically Relevant	1	MEL					Somatic variant	MITF
MEL-IPI_Pat04	NOTCH1.p.A1950T		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat04	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat04	NTRK1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	NTRK1 Amp
MEL-IPI_Pat04	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat06	ASXL1--LMAN2L	Biologically Relevant		1	MEL					Rearrangement	ASXL1--LMAN2L
MEL-IPI_Pat06	COL1A1--TGM2	Investigate Actionability		1	MEL	Guideline				Rearrangement	COL1A1--TGM2
MEL-IPI_Pat06	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat06	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat06	RAF1--NOP16	Investigate Actionability		1	MEL	Preclinical				Rearrangement	RAF1--NOP16
MEL-IPI_Pat07	BCOR.p.L808R	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BCOR
MEL-IPI_Pat07	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat07	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat07	EPHA5.p.Y211C		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat07	ERBB3.p.L441fs	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat07	ERBB3.p.Q932H	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat07	JAK1.p.G1097D	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat07	NF1.Splice_Site	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat07	PIK3R1.p.R262G		Biologically Relevant	1	MEL					Somatic variant	PIK3R1
MEL-IPI_Pat07	PMS2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PMS2 Amp
MEL-IPI_Pat07	TSC1.p.A943S	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat07	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat08	ALK.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ALK Del
MEL-IPI_Pat08	ATM.p.R337C	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat08	AURKA.Amplification	Putatively Actionable		1	MEL	Preclinical		Preclinical		Somatic copy number	AURKA Amp
MEL-IPI_Pat08	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat08	BRCA1.p.S819F	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat08	CDKN2A.p.R7*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat08	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat08	EML4.Deletion	Biologically Relevant		1	MEL					Somatic copy number	EML4 Del
MEL-IPI_Pat08	ESRP1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ESRP1 Amp
MEL-IPI_Pat08	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat08	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat08	SETBP1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	SETBP1 Del
MEL-IPI_Pat08	SMARCA4.p.E740Q	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	SMARCA4
MEL-IPI_Pat08	TMPRSS2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	TMPRSS2 Amp
MEL-IPI_Pat08	TSC1.p.L152I	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat08	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat100	ABL1.p.R1013Q	Investigate Actionability	Biologically Relevant	2	MEL		Guideline			Somatic variant	ABL1
MEL-IPI_Pat100	AURKB.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	AURKB Del
MEL-IPI_Pat100	BRIP1.p.N1087fs	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat100	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat100	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat100	EZH2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	EZH2 Amp
MEL-IPI_Pat100	FLCN.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLCN Del
MEL-IPI_Pat100	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat100	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat100	KEAP1.p.R470C	Biologically Relevant		1	MEL					Somatic variant	KEAP1
MEL-IPI_Pat100	MET.Amplification	Putatively Actionable		1	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat100	MPL.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MPL Amp
MEL-IPI_Pat100	MTOR.p.L2022F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat100	NF1.p.L499P	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat100	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat100	PDGFRB.Deletion	Biologically Relevant		1	MEL					Somatic copy number	PDGFRB Del
MEL-IPI_Pat100	POT1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	POT1 Amp
MEL-IPI_Pat100	SETBP1.p.S259F	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat100	TACC3.Splice_Site	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat100	TP53.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Guideline		Somatic variant	TP53
MEL-IPI_Pat100	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat101	BRAF.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat101	BRAF.p.D594Y	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat101	BRAF.p.L597I	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat101	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat101	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat101	COSMIC Signature 18	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 18
MEL-IPI_Pat101	ETV1.Amplification		Investigate Actionability	1	MEL					Somatic copy number	ETV1 Amp
MEL-IPI_Pat101	MTOR.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MTOR Amp
MEL-IPI_Pat101	NF1.p.R262H	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat101	NOTCH1.p.G1091S		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat101	NRAS.p.Q61R	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat101	NTRK2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	NTRK2 Amp
MEL-IPI_Pat101	PDGFB.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PDGFB Amp
MEL-IPI_Pat101	PIK3R1.Deletion		Investigate Actionability	1	MEL					Somatic copy number	PIK3R1 Del
MEL-IPI_Pat101	RET.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	RET Del
MEL-IPI_Pat101	ROS1.Deletion		Investigate Actionability	1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat101	RUNX1T1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RUNX1T1 Del
MEL-IPI_Pat101	SMAD4.Deletion		Investigate Actionability	1	MEL					Somatic copy number	SMAD4 Del
MEL-IPI_Pat101	SYK.Deletion		Investigate Actionability	1	MEL					Somatic copy number	SYK Del
MEL-IPI_Pat103	ALK.p.P254S	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat103	BRAF.p.D594N	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat103	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat103	ERBB4.p.G1217E		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat103	GATA3.p.R367Q	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	GATA3
MEL-IPI_Pat103	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat103	JAK1.p.H106Y	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat103	MTOR.p.P1167L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat103	NTRK3.p.D401N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat103	PBRM1.p.P1094L	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat103	PBRM1.p.P1094S	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat103	ROS1.p.P696L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat103	TACC3.p.P217S	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat103	TACC3.p.P591L	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat104	APC.Deletion		Investigate Actionability	1	MEL					Somatic copy number	APC Del
MEL-IPI_Pat104	BRAF.Amplification	Putatively Actionable		1	MEL		Clinical evidence			Somatic copy number	BRAF Amp
MEL-IPI_Pat104	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat104	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat104	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat104	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat105	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat105	COL1A1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	COL1A1 Amp
MEL-IPI_Pat105	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat105	ETV6.p.R105*	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ETV6
MEL-IPI_Pat105	FGFR3.Amplification	Biologically Relevant		1	MEL					Somatic copy number	FGFR3 Amp
MEL-IPI_Pat105	GNAS.p.R322W		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat106	CD274.Deletion	Investigate Actionability		1	MEL	Inferential				Somatic copy number	CD274 Del
MEL-IPI_Pat106	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat106	COSMIC Signature 15	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 15
MEL-IPI_Pat106	EML4.Deletion	Biologically Relevant		1	MEL					Somatic copy number	EML4 Del
MEL-IPI_Pat106	FLCN.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLCN Del
MEL-IPI_Pat106	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat106	MLH3.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MLH3 Amp
MEL-IPI_Pat106	SETBP1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	SETBP1 Del
MEL-IPI_Pat109	CDKN2A.p.P63L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat109	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat109	ERBB4.p.R1174Q		Investigate Actionability	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat109	ERG.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ERG Del
MEL-IPI_Pat109	FLT3.p.H809D	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat109	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat109	TP53.p.P278R	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat109	WT1.p.G126R		Biologically Relevant	1	MEL					Somatic variant	WT1
MEL-IPI_Pat109	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat11	ALK.p.G477D	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat11	APC.p.S2487F		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat11	ARID1A.p.P1425S	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat11	ASXL1.p.G645C	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ASXL1
MEL-IPI_Pat11	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat11	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat11	EZH2.p.E726K	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat11	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat11	LIMK2.p.P255L	Biologically Relevant		1	MEL					Somatic variant	LIMK2
MEL-IPI_Pat11	LIMK2.p.P255S	Biologically Relevant		1	MEL					Somatic variant	LIMK2
MEL-IPI_Pat11	MET.p.S1385F	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat11	NF2.p.A145V		Biologically Relevant	1	MEL					Somatic variant	NF2
MEL-IPI_Pat11	PRPF8.p.P2137L	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat11	ROS1.p.E94K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat11	ROS1.p.S1419F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat11	ROS1.p.S370T	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat11	SETBP1.p.S970F	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat11	SLC45A3.p.A307T	Biologically Relevant		1	MEL					Somatic variant	SLC45A3
MEL-IPI_Pat11	SMAD2.p.Q168*		Biologically Relevant	1	MEL					Somatic variant	SMAD2
MEL-IPI_Pat11	TP53.p.S241F	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat11	TSC1.p.S526F	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat11	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat110	ABL1.p.P310S	Investigate Actionability	Biologically Relevant	2	MEL		Guideline			Somatic variant	ABL1
MEL-IPI_Pat110	ABL1.p.R1013W	Investigate Actionability	Biologically Relevant	2	MEL		Guideline			Somatic variant	ABL1
MEL-IPI_Pat110	AKT1.p.E127K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	AKT1
MEL-IPI_Pat110	ALK.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ALK Amp
MEL-IPI_Pat110	ALK.p.D305N	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat110	APC.p.A591V		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat110	ARID1A.p.P1885S	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat110	ATM.p.E71K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat110	ATM.p.R1875*	Investigate Actionability	Biologically Relevant	2	MEL	Clinical trial				Somatic variant	ATM
MEL-IPI_Pat110	ATR.p.P2271S		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat110	BARD1.p.P315L	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	BARD1
MEL-IPI_Pat110	BCR.p.S371L	Investigate Actionability		1	MEL		Clinical evidence			Somatic variant	BCR
MEL-IPI_Pat110	BRCA1.p.E914K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat110	BRCA2.p.L901F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat110	BRIP1.p.P368L	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat110	CCNE1.p.P295S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CCNE1
MEL-IPI_Pat110	CDKN2A.p.R29*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat110	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat110	EGFR.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat110	EGFR.p.E59*	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat110	EPHA3.p.D129H		Biologically Relevant	1	MEL					Somatic variant	EPHA3
MEL-IPI_Pat110	EPHA3.p.S334F		Biologically Relevant	1	MEL					Somatic variant	EPHA3
MEL-IPI_Pat110	EPHA5.p.E633K		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat110	EPHA5.p.H664Y		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat110	ERBB2.p.S310F	Investigate Actionability	Investigate Actionability	2	MEL	Clinical evidence				Somatic variant	ERBB2
MEL-IPI_Pat110	ERBB4.p.G31E		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat110	ERBB4.p.G741E		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat110	ERBB4.p.H162Y		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat110	ERBB4.p.P651L		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat110	ERBB4.p.S38F		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat110	ERG.p.S222F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ERG
MEL-IPI_Pat110	ESRP1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ESRP1 Amp
MEL-IPI_Pat110	ESRP1.p.V477A	Biologically Relevant		1	MEL					Somatic variant	ESRP1
MEL-IPI_Pat110	ETV1.p.R368C		Biologically Relevant	1	MEL					Somatic variant	ETV1
MEL-IPI_Pat110	ETV6.p.A336T	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ETV6
MEL-IPI_Pat110	FGFR2.p.E769KSplice_Site	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat110	FGFR2.p.M585I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat110	FGFR2.p.M735I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat110	FGFR2.p.S790F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat110	FGFR2.p.T137I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat110	FIP1L1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	FIP1L1 Amp
MEL-IPI_Pat110	FLI1.Splice_Site	Biologically Relevant		1	MEL					Somatic variant	FLI1
MEL-IPI_Pat110	FLI1.p.G4DSplice_Site	Biologically Relevant		1	MEL					Somatic variant	FLI1
MEL-IPI_Pat110	FLI1.p.R20Q	Biologically Relevant		1	MEL					Somatic variant	FLI1
MEL-IPI_Pat110	FLT3.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat110	FLT3.p.F621I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat110	FLT3.p.S389L	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat110	GATA3.p.S162F	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	GATA3
MEL-IPI_Pat110	GNAQ.p.P127Q		Biologically Relevant	1	MEL					Somatic variant	GNAQ
MEL-IPI_Pat110	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat110	IL12RB1.p.E207K	Biologically Relevant		1	MEL					Somatic variant	IL12RB1
MEL-IPI_Pat110	KDR.p.R1032Q		Investigate Actionability	1	MEL					Somatic variant	KDR
MEL-IPI_Pat110	KIT.Amplification	Biologically Relevant		1	MEL					Somatic copy number	KIT Amp
MEL-IPI_Pat110	KIT.p.N822Y	Investigate Actionability	Investigate Actionability	2	MEL	Guideline		Guideline		Somatic variant	KIT
MEL-IPI_Pat110	KRAS.p.F156L	Investigate Actionability	Biologically Relevant	2	MEL	Clinical trial	Clinical trial	Clinical evidence		Somatic variant	KRAS
MEL-IPI_Pat110	LIMK2.p.A483T	Biologically Relevant		1	MEL					Somatic variant	LIMK2
MEL-IPI_Pat110	LIMK2.p.S531F	Biologically Relevant		1	MEL					Somatic variant	LIMK2
MEL-IPI_Pat110	MLH3.p.P850S	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	MLH3
MEL-IPI_Pat110	MSH6.p.L778F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat110	MSH6.p.L778P	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat110	MTOR.p.R1009W	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat110	MTOR.p.S2035F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat110	NF1.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	NF1 Del
MEL-IPI_Pat110	NF1.p.Q282*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat110	NOTCH1.p.A495V		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat110	NOTCH1.p.P2222S		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat110	NOTCH1.p.S1911F		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat110	NOTCH1.p.S2228F		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat110	NTRK3.p.D467N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat110	NTRK3.p.K466N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat110	NTRK3.p.P725L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat110	PAK1.Deletion	Investigate Actionability		1	MEL			Clinical evidence		Somatic copy number	PAK1 Del
MEL-IPI_Pat110	PDGFRA.Amplification	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	PDGFRA Amp
MEL-IPI_Pat110	PDGFRA.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat110	PDGFRA.p.K504Q	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat110	PDGFRB.p.P129S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	PDGFRB
MEL-IPI_Pat110	POLE.Deletion	Biologically Relevant		1	MEL					Somatic copy number	POLE Del
MEL-IPI_Pat110	PTCH1.p.P1282S		Biologically Relevant	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat110	RAF1.p.L136F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	RAF1
MEL-IPI_Pat110	ROS1.p.E1244K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat110	ROS1.p.G242E	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat110	ROS1.p.P1710S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat110	ROS1.p.P1929S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat110	ROS1.p.T2045TSplice_Site	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat110	RUNX1T1.p.D220N	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat110	RUNX1T1.p.E261K	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat110	RUNX1T1.p.E339K	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat110	RUNX1T1.p.M365I	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat110	SETBP1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	SETBP1 Del
MEL-IPI_Pat110	SETBP1.p.S305F	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat110	SLC45A3.p.G487D	Biologically Relevant		1	MEL					Somatic variant	SLC45A3
MEL-IPI_Pat110	SMARCA4.p.R966W	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical				Somatic variant	SMARCA4
MEL-IPI_Pat110	SYK.p.P229L		Biologically Relevant	1	MEL					Somatic variant	SYK
MEL-IPI_Pat110	TET2.p.P413L	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat110	TP53.p.C176G	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat110	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat113	AURKB.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	AURKB Del
MEL-IPI_Pat113	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat113	GNAS.p.G92E		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat113	KDR.p.V344M		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat113	NTRK2.p.D258N	Biologically Relevant		1	MEL					Somatic variant	NTRK2
MEL-IPI_Pat113	PIK3CA.p.H1047R	Putatively Actionable	Putatively Actionable	2	MEL	Preclinical		Clinical trial		Somatic variant	PIK3CA
MEL-IPI_Pat113	TET2.p.S792L	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat115	AKT1--ZNF850	Biologically Relevant		1	MEL					Rearrangement	AKT1--ZNF850
MEL-IPI_Pat115	BLM.p.F876L	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BLM
MEL-IPI_Pat115	CHEK1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK1 Del
MEL-IPI_Pat115	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat115	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat115	ERBB3--SLC27A2	Biologically Relevant		1	MEL					Rearrangement	ERBB3--SLC27A2
MEL-IPI_Pat115	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat115	PAK1.Amplification	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	PAK1 Amp
MEL-IPI_Pat115	POLE.Deletion	Biologically Relevant		1	MEL					Somatic copy number	POLE Del
MEL-IPI_Pat115	RET.p.D892N	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	RET
MEL-IPI_Pat115	RP11-705C15.3--PRPF8	Biologically Relevant		1	MEL					Rearrangement	RP11-705C15.3--PRPF8
MEL-IPI_Pat115	TMEM2--ERBB3	Biologically Relevant		1	MEL					Rearrangement	TMEM2--ERBB3
MEL-IPI_Pat115	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat117	ASXL1--MT-RNR2	Biologically Relevant		1	MEL					Rearrangement	ASXL1--MT-RNR2
MEL-IPI_Pat117	BRCA1.p.P1575L	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat117	CAMSAP1--COL1A1	Investigate Actionability		1	MEL	Guideline				Rearrangement	CAMSAP1--COL1A1
MEL-IPI_Pat117	COL1A1.p.T103I	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat117	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat117	CTNNB1--MLKL	Biologically Relevant		1	MEL					Rearrangement	CTNNB1--MLKL
MEL-IPI_Pat117	EED--EZH2	Biologically Relevant		1	MEL					Rearrangement	EED--EZH2
MEL-IPI_Pat117	FASN--PTPN11	Biologically Relevant		1	MEL					Rearrangement	FASN--PTPN11
MEL-IPI_Pat117	GFOD2--SF3B1	Biologically Relevant		1	MEL					Rearrangement	GFOD2--SF3B1
MEL-IPI_Pat117	GNAS.p.S117F		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat117	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat117	IGF1R.p.W916*		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat117	KDR.p.P1253L		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat117	MALAT1--CCND1	Investigate Actionability		1	MEL	Inferential		Clinical evidence		Rearrangement	MALAT1--CCND1
MEL-IPI_Pat117	MAP2K1.p.Q56P	Putatively Actionable	Putatively Actionable	2	MEL	Preclinical	Preclinical			Somatic variant	MAP2K1
MEL-IPI_Pat117	MAP2K4.p.S331F		Biologically Relevant	1	MEL					Somatic variant	MAP2K4
MEL-IPI_Pat117	MET.p.G1037D	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat117	MT-RNR2--CCND1	Investigate Actionability		1	MEL	Inferential		Clinical evidence		Rearrangement	MT-RNR2--CCND1
MEL-IPI_Pat117	NCAPG--JAK1	Biologically Relevant		1	MEL					Rearrangement	NCAPG--JAK1
MEL-IPI_Pat117	NF1--RUNX1	Investigate Actionability		1	MEL	Preclinical				Rearrangement	NF1--RUNX1
MEL-IPI_Pat117	NTRK1.p.P302L	Biologically Relevant		1	MEL					Somatic variant	NTRK1
MEL-IPI_Pat117	OXA1L--PRPF8	Biologically Relevant		1	MEL					Rearrangement	OXA1L--PRPF8
MEL-IPI_Pat117	PALB2.p.S835F	Investigate Actionability		1	MEL	Clinical evidence		Inferential		Somatic variant	PALB2
MEL-IPI_Pat117	SMO.p.R257Q		Biologically Relevant	1	MEL					Somatic variant	SMO
MEL-IPI_Pat117	TOMM20--IDH2	Biologically Relevant		1	MEL					Rearrangement	TOMM20--IDH2
MEL-IPI_Pat117	TPX2--TBK1	Biologically Relevant		1	MEL					Rearrangement	TPX2--TBK1
MEL-IPI_Pat118	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat118	CDKN2A.p.E37*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat118	CMTM3--AKT2	Biologically Relevant		1	MEL					Rearrangement	CMTM3--AKT2
MEL-IPI_Pat118	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat118	HIPK2--ETV6	Biologically Relevant		1	MEL					Rearrangement	HIPK2--ETV6
MEL-IPI_Pat118	MALAT1--ERBB3	Biologically Relevant		1	MEL					Rearrangement	MALAT1--ERBB3
MEL-IPI_Pat118	PBRM1.p.P179S	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat118	RBM10.p.G112R	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	RBM10
MEL-IPI_Pat118	RP11-435B5.4--PBRM1	Biologically Relevant		1	MEL					Rearrangement	RP11-435B5.4--PBRM1
MEL-IPI_Pat118	XIST--COL1A1	Investigate Actionability		1	MEL	Guideline				Rearrangement	XIST--COL1A1
MEL-IPI_Pat118	XXYLT1--RUNX1	Investigate Actionability		1	MEL	Preclinical				Rearrangement	XXYLT1--RUNX1
MEL-IPI_Pat119	AC104820.2--RB1	Biologically Relevant		1	MEL					Rearrangement	AC104820.2--RB1
MEL-IPI_Pat119	ATM.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ATM Del
MEL-IPI_Pat119	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat119	EGFR.Deletion	Investigate Actionability		1	MEL	Clinical evidence				Somatic copy number	EGFR Del
MEL-IPI_Pat119	IGF1R.p.D654N		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat119	IGF1R.p.Q653K		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat119	JAK2--RBM26	Biologically Relevant		1	MEL					Rearrangement	JAK2--RBM26
MEL-IPI_Pat119	MIR17HG.Amplification	Putatively Actionable		1	MEL	Preclinical	Preclinical			Somatic copy number	MIR17HG Amp
MEL-IPI_Pat119	MT-RNR2--MLH1	Biologically Relevant		1	MEL					Rearrangement	MT-RNR2--MLH1
MEL-IPI_Pat119	MTOR--YME1L1	Biologically Relevant		1	MEL					Rearrangement	MTOR--YME1L1
MEL-IPI_Pat119	NRAS.p.Q61R	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat119	RET.p.E480K	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	RET
MEL-IPI_Pat119	ROS1.p.G1196R	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat119	ULK4--CTNNB1	Biologically Relevant		1	MEL					Rearrangement	ULK4--CTNNB1
MEL-IPI_Pat121	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat123	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat123	EWSR1.p.P473Q	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	EWSR1
MEL-IPI_Pat123	EWSR1.p.P473S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	EWSR1
MEL-IPI_Pat123	GATA3.p.S438N	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	GATA3
MEL-IPI_Pat123	GNAS.p.E190K		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat123	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat123	MALAT1--ERBB3	Biologically Relevant		1	MEL					Rearrangement	MALAT1--ERBB3
MEL-IPI_Pat123	NF1.p.L1946S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat123	NRAS.p.Q61R	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat123	ROS1.p.P437S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat124	ABL1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ABL1 Del
MEL-IPI_Pat124	BRCA2.p.2136_2138LNV>F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat124	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat124	ERBB4.p.R1304Q		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat124	ESRP1.p.G302D	Biologically Relevant		1	MEL					Somatic variant	ESRP1
MEL-IPI_Pat124	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat124	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat124	MIR17HG.Amplification	Putatively Actionable		1	MEL	Preclinical	Preclinical			Somatic copy number	MIR17HG Amp
MEL-IPI_Pat124	MSH2.p.I691V	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat124	TSC1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	TSC1 Del
MEL-IPI_Pat124	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat126	CHEK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK2 Del
MEL-IPI_Pat126	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat126	ERBB4.p.R124K		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat126	ERCC2.p.P123L	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERCC2
MEL-IPI_Pat126	EWSR1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	EWSR1 Del
MEL-IPI_Pat126	FGFR1.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR1 Del
MEL-IPI_Pat126	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat126	LIMK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Del
MEL-IPI_Pat126	MTOR.p.P1117L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat126	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat126	PALB2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	PALB2 Del
MEL-IPI_Pat126	TSC1.p.L33F	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat126	TSC2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	TSC2 Amp
MEL-IPI_Pat127	ATR.p.S476F		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat127	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat127	CDKN2A.p.W59*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat127	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat127	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat127	GNAS.p.D64N		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat127	MET.Amplification	Putatively Actionable		1	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat127	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat127	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat128	ATM.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Clinical trial				Somatic variant	ATM
MEL-IPI_Pat128	BLM.Amplification	Biologically Relevant		1	MEL					Somatic copy number	BLM Amp
MEL-IPI_Pat128	BRAF.p.L505H	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat128	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat128	CDK4--PRKAR1A	Biologically Relevant		1	MEL					Rearrangement	CDK4--PRKAR1A
MEL-IPI_Pat128	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat128	CTNNB1--SNORA49	Biologically Relevant		1	MEL					Rearrangement	CTNNB1--SNORA49
MEL-IPI_Pat128	FLT3.p.P986L	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat128	IDH2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	IDH2 Amp
MEL-IPI_Pat128	MAP2K1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MAP2K1 Amp
MEL-IPI_Pat128	NTRK3.Amplification	Biologically Relevant		1	MEL					Somatic copy number	NTRK3 Amp
MEL-IPI_Pat128	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat128	RLF--MSH6	Biologically Relevant		1	MEL					Rearrangement	RLF--MSH6
MEL-IPI_Pat128	SNRPD1--CTNNB1	Biologically Relevant		1	MEL					Rearrangement	SNRPD1--CTNNB1
MEL-IPI_Pat128	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat129	AR.p.D545N	Investigate Actionability	Biologically Relevant	2	MEL		Clinical evidence			Somatic variant	AR
MEL-IPI_Pat129	ARID4A--CDK4	Biologically Relevant		1	MEL					Rearrangement	ARID4A--CDK4
MEL-IPI_Pat129	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat129	CHD3--COL1A1	Investigate Actionability		1	MEL	Guideline				Rearrangement	CHD3--COL1A1
MEL-IPI_Pat129	COL1A1--MT-ND1	Investigate Actionability		1	MEL	Guideline				Rearrangement	COL1A1--MT-ND1
MEL-IPI_Pat129	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat129	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat129	CTNNB1--CARS	Biologically Relevant		1	MEL					Rearrangement	CTNNB1--CARS
MEL-IPI_Pat129	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat129	FMNL3--PRPF8	Biologically Relevant		1	MEL					Rearrangement	FMNL3--PRPF8
MEL-IPI_Pat129	MET.Amplification	Putatively Actionable		1	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat129	MLH3--HDGF	Biologically Relevant		1	MEL					Rearrangement	MLH3--HDGF
MEL-IPI_Pat129	MT-RNR2--IDH1	Biologically Relevant		1	MEL					Rearrangement	MT-RNR2--IDH1
MEL-IPI_Pat129	NFE2L2--RP11-112J1.1	Biologically Relevant		1	MEL					Rearrangement	NFE2L2--RP11-112J1.1
MEL-IPI_Pat129	POT1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	POT1 Amp
MEL-IPI_Pat129	RAC1P2--MTOR	Biologically Relevant		1	MEL					Rearrangement	RAC1P2--MTOR
MEL-IPI_Pat129	TAB2--NFE2L2	Biologically Relevant		1	MEL					Rearrangement	TAB2--NFE2L2
MEL-IPI_Pat129	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat13	ALK.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ALK Amp
MEL-IPI_Pat13	BRAF.p.D594Y	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat13	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat13	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat13	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat13	FGFR2.p.S282R	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat13	MEN1.p.Q96*		Biologically Relevant	1	MEL					Somatic variant	MEN1
MEL-IPI_Pat13	NRAS.Amplification	Biologically Relevant		1	MEL					Somatic copy number	NRAS Amp
MEL-IPI_Pat13	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat13	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat13	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat130	AKT3.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	AKT3 Del
MEL-IPI_Pat130	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat130	CCND1.p.E36K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CCND1
MEL-IPI_Pat130	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat130	ERG.p.S265L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ERG
MEL-IPI_Pat130	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat130	MAP2K1.p.C121S	Putatively Actionable	Putatively Actionable	2	MEL	Preclinical	Preclinical			Somatic variant	MAP2K1
MEL-IPI_Pat130	NF1.p.R601Q	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat130	POLE.p.P2154S	Investigate Actionability		1	MEL	Inferential		Clinical evidence		Somatic variant	POLE
MEL-IPI_Pat130	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat130	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat131	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat131	TSC2.p.R505Q	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat132	APC.p.S2512N		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat132	ASXL1.p.E528K	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ASXL1
MEL-IPI_Pat132	ATM.p.D2841N	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat132	ATM.p.E1220K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat132	ATM.p.P1566L	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat132	ATM.p.V1629M	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat132	ATR.p.A1291T		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat132	ATR.p.P315S		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat132	BLM.p.G891E	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BLM
MEL-IPI_Pat132	BRAF.p.E193K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat132	BRAF.p.V197A	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat132	BRCA2.p.G1218S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat132	BRCA2.p.S3291F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat132	BRIP1.p.A1030V	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat132	BRIP1.p.A776T	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat132	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat132	CRKL.Amplification	Putatively Actionable		1	MEL		Clinical evidence			Somatic copy number	CRKL Amp
MEL-IPI_Pat132	EPHA3.p.N31K		Biologically Relevant	1	MEL					Somatic variant	EPHA3
MEL-IPI_Pat132	EZH2.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat132	FBXW7.p.G667R	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat132	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat132	IGF1R.p.R1133K		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat132	KDR.p.S544F		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat132	KRAS.p.A18T	Investigate Actionability	Investigate Actionability	2	MEL	Clinical trial	Clinical trial	Clinical evidence		Somatic variant	KRAS
MEL-IPI_Pat132	MAPK1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MAPK1 Amp
MEL-IPI_Pat132	MDM2.p.G428D	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MDM2
MEL-IPI_Pat132	MSH6.p.T1219I	Investigate Actionability	Investigate Actionability	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat132	MTOR.p.E883K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat132	NF1.p.A656T	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat132	NF1.p.D1237NSplice_Site	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat132	NF1.p.V1578I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat132	PAK1.p.G32E	Biologically Relevant		1	MEL					Somatic variant	PAK1
MEL-IPI_Pat132	PDGFRA.p.P345L	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat132	PDGFRB.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PDGFRB Amp
MEL-IPI_Pat132	PIK3R1.p.E133K		Biologically Relevant	1	MEL					Somatic variant	PIK3R1
MEL-IPI_Pat132	PIK3R1.p.L264F		Biologically Relevant	1	MEL					Somatic variant	PIK3R1
MEL-IPI_Pat132	PIK3R1.p.V300MSplice_Site		Biologically Relevant	1	MEL					Somatic variant	PIK3R1
MEL-IPI_Pat132	PMS2.p.V32I	Biologically Relevant		1	MEL					Somatic variant	PMS2
MEL-IPI_Pat132	POT1.p.T41I	Biologically Relevant		1	MEL					Somatic variant	POT1
MEL-IPI_Pat132	PRPF8.p.K727KSplice_Site	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat132	PTCH1.p.P225L		Biologically Relevant	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat132	PTEN.p.E307K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MEL-IPI_Pat132	PTEN.p.Y27NSplice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MEL-IPI_Pat132	RAD51C.p.L297F	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	RAD51C
MEL-IPI_Pat132	STAG2.p.A867T	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat132	STAG2.p.D198N	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat132	STAG2.p.E16KSplice_Site	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat132	STAG2.p.R252L	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat132	STAG2.p.W315*	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat132	SYK.p.E357K		Biologically Relevant	1	MEL					Somatic variant	SYK
MEL-IPI_Pat132	TET2.p.V1056I	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat132	TPX2.p.P422S	Biologically Relevant		1	MEL					Somatic variant	TPX2
MEL-IPI_Pat132	TPX2.p.P427S	Biologically Relevant		1	MEL					Somatic variant	TPX2
MEL-IPI_Pat132	TSC1.p.A883V	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat132	XPO1.Splice_Site		Investigate Actionability	1	MEL					Somatic variant	XPO1
MEL-IPI_Pat132	XPO1.p.D1029N		Biologically Relevant	1	MEL					Somatic variant	XPO1
MEL-IPI_Pat133	ARID1A.p.P855S	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat133	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat133	EZH2.p.H521Y	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat133	POLE2.p.V335G	Biologically Relevant		1	MEL					Somatic variant	POLE2
MEL-IPI_Pat133	RAD51D.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RAD51D Del
MEL-IPI_Pat133	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat135	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat135	ESR1.Deletion	Investigate Actionability		1	MEL			Clinical evidence		Somatic copy number	ESR1 Del
MEL-IPI_Pat135	ETV1.Amplification		Investigate Actionability	1	MEL					Somatic copy number	ETV1 Amp
MEL-IPI_Pat135	FGFR1.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR1 Del
MEL-IPI_Pat135	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat135	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat135	PTEN.Deletion	Putatively Actionable		1	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat135	RET.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RET Del
MEL-IPI_Pat135	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat135	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat138	ABL1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ABL1 Del
MEL-IPI_Pat138	ALK.p.E1526K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat138	ALK.p.Y1507C	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat138	APC.p.R1435K		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat138	ARAF.p.G163E	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ARAF
MEL-IPI_Pat138	ARID1A.p.P198L	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat138	ARID1A.p.S593F	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat138	ASXL1.p.S79N	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ASXL1
MEL-IPI_Pat138	ATM.p.L1606F	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat138	ATR.p.G94D		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat138	ATR.p.R2454K		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat138	BCR.p.S222N	Investigate Actionability		1	MEL		Clinical evidence			Somatic variant	BCR
MEL-IPI_Pat138	BLM.Deletion	Biologically Relevant		1	MEL					Somatic copy number	BLM Del
MEL-IPI_Pat138	BLM.p.G1011E	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BLM
MEL-IPI_Pat138	BRCA1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	BRCA1 Amp
MEL-IPI_Pat138	BRCA1.p.A579T	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat138	BRCA1.p.N1272D	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat138	BRCA1.p.S1217F	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat138	BRCA2.p.P1702S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat138	BRCA2.p.T1505I	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat138	BRIP1.p.D127DSplice_Site	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat138	BRIP1.p.P210LSplice_Site	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat138	BRIP1.p.T1059I	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat138	CCNE1.p.N326S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CCNE1
MEL-IPI_Pat138	CDKN1B.p.G202D		Biologically Relevant	1	MEL					Somatic variant	CDKN1B
MEL-IPI_Pat138	CHEK2.p.S235L	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	CHEK2
MEL-IPI_Pat138	COL1A1.p.G1272ESplice_Site	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat138	COL1A1.p.P376S	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat138	COL1A1.p.P978S	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat138	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat138	CREBBP.p.A2106V		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat138	CREBBP.p.A789T		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat138	CREBBP.p.A840T		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat138	CTNNB1.p.D299N	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	CTNNB1
MEL-IPI_Pat138	EML4.p.P202S	Biologically Relevant		1	MEL					Somatic variant	EML4
MEL-IPI_Pat138	EPHA3.p.S622F		Biologically Relevant	1	MEL					Somatic variant	EPHA3
MEL-IPI_Pat138	ERBB2.p.D982E	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB2
MEL-IPI_Pat138	ERBB2.p.P66L	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB2
MEL-IPI_Pat138	ERBB3.p.P223S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat138	ERBB3.p.R1089Q	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat138	ERBB4.p.P409L		Investigate Actionability	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat138	ERCC2.p.S322F	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERCC2
MEL-IPI_Pat138	ERG.p.W152*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ERG
MEL-IPI_Pat138	ETV5.p.D238N		Biologically Relevant	1	MEL					Somatic variant	ETV5
MEL-IPI_Pat138	EZH2.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	EZH2 Del
MEL-IPI_Pat138	FBXW7.p.G579E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat138	FBXW7.p.H382Y	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat138	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat138	FLCN.p.D33N	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	FLCN
MEL-IPI_Pat138	GNAS.p.T321I		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat138	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat138	IGF1R.Deletion		Investigate Actionability	1	MEL					Somatic copy number	IGF1R Del
MEL-IPI_Pat138	IGF1R.p.G129E		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat138	KEAP1.p.S431F	Biologically Relevant		1	MEL					Somatic variant	KEAP1
MEL-IPI_Pat138	MAP2K2.p.E142K	Investigate Actionability	Biologically Relevant	2	MEL		Clinical evidence			Somatic variant	MAP2K2
MEL-IPI_Pat138	MAP2K2.p.G132D	Investigate Actionability	Biologically Relevant	2	MEL		Clinical evidence			Somatic variant	MAP2K2
MEL-IPI_Pat138	MDM2.p.E398K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MDM2
MEL-IPI_Pat138	MET.p.S653F	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat138	MLH1.p.S179F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MLH1
MEL-IPI_Pat138	MLH3.p.D707N	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	MLH3
MEL-IPI_Pat138	MLH3.p.G23S	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	MLH3
MEL-IPI_Pat138	MLH3.p.R797C	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	MLH3
MEL-IPI_Pat138	MSH2.p.E489K	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat138	MSH2.p.G221R	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat138	MSH6.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat138	MSH6.p.T1219I	Investigate Actionability	Investigate Actionability	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat138	NF1.p.L1340F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat138	NFE2L2.p.P210S	Investigate Actionability		1	MEL		Preclinical			Somatic variant	NFE2L2
MEL-IPI_Pat138	NFE2L2.p.S236F	Investigate Actionability		1	MEL		Preclinical			Somatic variant	NFE2L2
MEL-IPI_Pat138	NOTCH1.p.G1975S		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat138	NOTCH2.p.A1654V		Biologically Relevant	1	MEL					Somatic variant	NOTCH2
MEL-IPI_Pat138	NOTCH2.p.C1425Y		Biologically Relevant	1	MEL					Somatic variant	NOTCH2
MEL-IPI_Pat138	NOTCH2.p.P2219L		Biologically Relevant	1	MEL					Somatic variant	NOTCH2
MEL-IPI_Pat138	NOTCH2.p.Y1186H		Biologically Relevant	1	MEL					Somatic variant	NOTCH2
MEL-IPI_Pat138	PBRM1.p.S1386N	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat138	PIK3CB.p.Y618H	Investigate Actionability		1	MEL	Preclinical				Somatic variant	PIK3CB
MEL-IPI_Pat138	PMS2.p.P566S	Biologically Relevant		1	MEL					Somatic variant	PMS2
MEL-IPI_Pat138	PMS2.p.Q275*	Biologically Relevant		1	MEL					Somatic variant	PMS2
MEL-IPI_Pat138	POLD1.p.G106SSplice_Site	Investigate Actionability		1	MEL	Inferential		Clinical evidence		Somatic variant	POLD1
MEL-IPI_Pat138	POLE.p.L1245F	Investigate Actionability		1	MEL	Inferential		Clinical evidence		Somatic variant	POLE
MEL-IPI_Pat138	POLE2.p.T135I	Biologically Relevant		1	MEL					Somatic variant	POLE2
MEL-IPI_Pat138	POT1.p.P537L	Biologically Relevant		1	MEL					Somatic variant	POT1
MEL-IPI_Pat138	PRPF8.p.A2201T	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat138	PTCH1.p.P1182S		Biologically Relevant	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat138	PTEN.p.K183fs	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MEL-IPI_Pat138	RET.p.E1006K	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	RET
MEL-IPI_Pat138	ROS1.p.A1036T	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat138	ROS1.p.R187T	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat138	RUNX1.p.L321F	Investigate Actionability	Biologically Relevant	2	MEL			Guideline		Somatic variant	RUNX1
MEL-IPI_Pat138	SETBP1.p.G287E	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat138	SMAD2.p.G113D		Biologically Relevant	1	MEL					Somatic variant	SMAD2
MEL-IPI_Pat138	STAG2.p.Q15QSplice_Site	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat138	TACC3.p.P417S	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat138	TACC3.p.V531ISplice_Site	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat138	TPX2.p.A85T	Biologically Relevant		1	MEL					Somatic variant	TPX2
MEL-IPI_Pat138	TSC2.p.A1171V	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat138	TSC2.p.L119F	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat138	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat138	ZRSR2.Splice_Site	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	ZRSR2
MEL-IPI_Pat139	APC.p.R2237*		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat139	ASXL1.p.P148T	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ASXL1
MEL-IPI_Pat139	AURKB.p.E114K	Biologically Relevant		1	MEL					Somatic variant	AURKB
MEL-IPI_Pat139	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat139	EPCAM.p.D206N	Biologically Relevant		1	MEL					Somatic variant	EPCAM
MEL-IPI_Pat139	ERBB4.p.P920S		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat139	EWSR1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	EWSR1 Amp
MEL-IPI_Pat139	GNAS.p.R601Q		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat139	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat139	KRAS.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	KRAS Del
MEL-IPI_Pat139	MAP2K4.p.P392S		Biologically Relevant	1	MEL					Somatic variant	MAP2K4
MEL-IPI_Pat139	MDM2.Amplification	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	MDM2 Amp
MEL-IPI_Pat139	MITF.Amplification		Investigate Actionability	1	MEL					Somatic copy number	MITF Amp
MEL-IPI_Pat139	NF1.p.S2132F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat139	NRAS.p.I55V	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat139	NRAS.p.Q61L	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat139	NTRK1.p.R686C	Biologically Relevant		1	MEL					Somatic variant	NTRK1
MEL-IPI_Pat139	PDGFRA.p.S461F	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat139	RUNX1T1.p.H549Y	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat139	RUNX1T1.p.R316*	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat139	SETBP1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	SETBP1 Del
MEL-IPI_Pat139	SETBP1.p.E850K	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat139	SF3B1.p.L1038F	Investigate Actionability		1	MEL			Guideline		Somatic variant	SF3B1
MEL-IPI_Pat139	SF3B1.p.V571A	Investigate Actionability		1	MEL			Guideline		Somatic variant	SF3B1
MEL-IPI_Pat139	SMARCA4.p.S1060F	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	SMARCA4
MEL-IPI_Pat139	TET2.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	TET2 Del
MEL-IPI_Pat139	TMPRSS2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	TMPRSS2 Amp
MEL-IPI_Pat139	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat14	ATM.p.E1666fs	Investigate Actionability	Biologically Relevant	2	MEL	Clinical trial				Somatic variant	ATM
MEL-IPI_Pat14	AURKB.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	AURKB Del
MEL-IPI_Pat14	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat14	COL1A1--FN1	Investigate Actionability		1	MEL	Guideline				Rearrangement	COL1A1--FN1
MEL-IPI_Pat14	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat14	FGFR3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FGFR3 Del
MEL-IPI_Pat14	JAK1.p.G590R	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat14	MYC.Amplification	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	MYC Amp
MEL-IPI_Pat14	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat140	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat140	CREBBP.p.P248L		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat140	DDR2.p.E844K		Biologically Relevant	1	MEL					Somatic variant	DDR2
MEL-IPI_Pat140	EPHA5.p.K521*		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat140	ERG.p.M385I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ERG
MEL-IPI_Pat140	ERRFI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ERRFI1 Del
MEL-IPI_Pat140	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat140	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat140	PDGFRA.p.E996K	Investigate Actionability	Investigate Actionability	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat140	RB1.p.H483Y	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	RB1
MEL-IPI_Pat140	ROS1.p.C392Y	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat140	TSC2.p.E216K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat143	APC.p.S2461L		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat143	BLM.Amplification	Biologically Relevant		1	MEL					Somatic copy number	BLM Amp
MEL-IPI_Pat143	BRAF.p.E586K	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat143	COL1A1.p.E1011K	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat143	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat143	EPHA3.p.Y736C		Biologically Relevant	1	MEL					Somatic variant	EPHA3
MEL-IPI_Pat143	ERBB4.p.R1139Q		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat143	FLT3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLT3 Del
MEL-IPI_Pat143	GATA3.p.S172L	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	GATA3
MEL-IPI_Pat143	GNAS.p.G618S		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat143	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat143	MET.Amplification	Putatively Actionable		1	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat143	MET.p.V1305I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat143	NRAS.p.Q61L	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat143	PRPF8.p.R1414C	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat143	RAD51D.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RAD51D Del
MEL-IPI_Pat143	RB1.p.D111N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	RB1
MEL-IPI_Pat143	SETBP1.p.A436V	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat143	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat143	XPO1.p.V421A		Biologically Relevant	1	MEL					Somatic variant	XPO1
MEL-IPI_Pat147	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat147	BRAF.p.V600M	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat147	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat147	CTNNB1.p.S33P	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	CTNNB1
MEL-IPI_Pat147	DDR2.p.V140MSplice_Site		Biologically Relevant	1	MEL					Somatic variant	DDR2
MEL-IPI_Pat147	ERBB4.p.G286E		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat147	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat147	PTCH1.p.P253S		Biologically Relevant	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat147	ROS1.p.E2027K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat147	ROS1.p.G799E	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat147	ROS1.p.Y800N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat148	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat148	BRCA2.p.N679D	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat148	CHEK2.p.P92L	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	CHEK2
MEL-IPI_Pat148	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat148	DNMT3A.Deletion	Biologically Relevant		1	MEL					Somatic copy number	DNMT3A Del
MEL-IPI_Pat148	ERBB3.p.R580*	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat148	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat148	PIK3CB.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PIK3CB Amp
MEL-IPI_Pat148	RUNX1T1.p.R31C	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat148	RUNX1T1.p.W9*	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat148	TP53.p.Q38*	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Guideline		Somatic variant	TP53
MEL-IPI_Pat148	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat15	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat15	CDKN2A.Splice_Site	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat15	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat15	ERBB3.p.D1129H	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat15	NFE2L2.p.L107F	Investigate Actionability		1	MEL		Preclinical			Somatic variant	NFE2L2
MEL-IPI_Pat15	RUNX1T1.p.E238K	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat15	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat151	ALK.p.G574E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat151	ATM.p.V2284I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat151	ATR.p.G1074R		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat151	ATR.p.P1637L		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat151	AURKA.p.P106S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	AURKA
MEL-IPI_Pat151	BRAF.p.G761D	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat151	BRCA2.p.A3176V	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat151	BRCA2.p.G402D	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat151	BRD2.p.L420F		Biologically Relevant	1	MEL					Somatic variant	BRD2
MEL-IPI_Pat151	BRD4.p.S401N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	BRD4
MEL-IPI_Pat151	CD274.p.T221I	Biologically Relevant		1	MEL					Somatic variant	CD274
MEL-IPI_Pat151	CHEK1.p.R181K	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	CHEK1
MEL-IPI_Pat151	COL1A1.p.G836D	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat151	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat151	CREBBP.p.P279L		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat151	EPHA5.p.G260D		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat151	ESR1.Deletion	Investigate Actionability		1	MEL			Clinical evidence		Somatic copy number	ESR1 Del
MEL-IPI_Pat151	ETV1.p.T305I		Biologically Relevant	1	MEL					Somatic variant	ETV1
MEL-IPI_Pat151	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat151	IDH1.p.A341V	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved		Guideline		Somatic variant	IDH1
MEL-IPI_Pat151	IGF1R.p.W14*		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat151	JAK1.p.G655D	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat151	JAK1.p.V715M	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat151	MET.p.G890D	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat151	MET.p.R811H	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat151	MLH3.p.A177V	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	MLH3
MEL-IPI_Pat151	MSH6.p.E544K	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat151	MSH6.p.Q835*	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat151	MSH6.p.V143I	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat151	NF1.p.G2499D	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat151	NF1.p.P2303S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat151	NOTCH1.p.A1700T		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat151	NRAS.p.A59T	Investigate Actionability	Investigate Actionability	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat151	NTRK3.p.A282V	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat151	PAK1.p.G510D	Biologically Relevant		1	MEL					Somatic variant	PAK1
MEL-IPI_Pat151	PBRM1.p.V804A	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat151	PDGFB.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PDGFB Amp
MEL-IPI_Pat151	PDGFB.p.S75N	Biologically Relevant		1	MEL					Somatic variant	PDGFB
MEL-IPI_Pat151	PMS2.p.D286N	Biologically Relevant		1	MEL					Somatic variant	PMS2
MEL-IPI_Pat151	PMS2.p.G232E	Biologically Relevant		1	MEL					Somatic variant	PMS2
MEL-IPI_Pat151	PRPF8.Splice_Site	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat151	PTEN.p.S170N	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MEL-IPI_Pat151	RAD51C.p.A55V	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	RAD51C
MEL-IPI_Pat151	RB1.p.V833I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	RB1
MEL-IPI_Pat151	ROS1.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat151	SF3B1.p.A713T	Investigate Actionability		1	MEL			Guideline		Somatic variant	SF3B1
MEL-IPI_Pat151	TACC3.p.D709N	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat151	TSC1.p.A1129T	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat157	ATM.p.L2198I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat157	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat157	BRCA1.p.R1443Q	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat157	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat157	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat157	ESR1.Deletion	Investigate Actionability		1	MEL			Clinical evidence		Somatic copy number	ESR1 Del
MEL-IPI_Pat157	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat157	LIMK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Del
MEL-IPI_Pat157	NF1.p.Q1399K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat157	RAF1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RAF1 Del
MEL-IPI_Pat157	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat157	STAG2.p.L716F	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat157	TMPRSS2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	TMPRSS2 Amp
MEL-IPI_Pat159	ARID1A.p.P676T	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat159	ATM.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ATM Del
MEL-IPI_Pat159	BRCA1.p.Q262*	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat159	BRCA2.p.S1597F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat159	CDKN2A.p.D23N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat159	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat159	EGFR.Deletion	Investigate Actionability		1	MEL	Clinical evidence				Somatic copy number	EGFR Del
MEL-IPI_Pat159	ESR1.Deletion	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic copy number	ESR1 Del
MEL-IPI_Pat159	ESRP1.p.R415Q	Biologically Relevant		1	MEL					Somatic variant	ESRP1
MEL-IPI_Pat159	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat159	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat159	MDM4.p.L249S		Biologically Relevant	1	MEL					Somatic variant	MDM4
MEL-IPI_Pat159	MTOR.p.R2152C	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat159	NF1.p.L1109*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat159	NF1.p.Q400*	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat159	NTRK1.p.L120LSplice_Site	Biologically Relevant		1	MEL					Somatic variant	NTRK1
MEL-IPI_Pat159	PTPN11.p.A461TSplice_Site	Investigate Actionability		1	MEL			Guideline		Somatic variant	PTPN11
MEL-IPI_Pat159	PTPN11.p.G462E	Investigate Actionability		1	MEL			Guideline		Somatic variant	PTPN11
MEL-IPI_Pat159	PTPN11.p.H419Y	Investigate Actionability		1	MEL			Guideline		Somatic variant	PTPN11
MEL-IPI_Pat159	TPX2.p.E211*	Biologically Relevant		1	MEL					Somatic variant	TPX2
MEL-IPI_Pat159	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat16	ABL1.p.E494K	Investigate Actionability	Biologically Relevant	2	MEL		Guideline			Somatic variant	ABL1
MEL-IPI_Pat16	BCOR.p.K212R	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BCOR
MEL-IPI_Pat16	BRCA1.p.D435E	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat16	BRCA1.p.D435V	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat16	CDKN2A.p.P63L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat16	CHEK1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK1 Del
MEL-IPI_Pat16	COL1A1.Splice_Site	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat16	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat16	EGFR.p.D792N	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat16	EGFR.p.E642K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat16	EPHA3.p.E264K		Biologically Relevant	1	MEL					Somatic variant	EPHA3
MEL-IPI_Pat16	ERBB4.p.E563K		Investigate Actionability	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat16	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat16	FLT3.p.E415K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat16	HRAS.p.G13D		Investigate Actionability	1	MEL					Somatic variant	HRAS
MEL-IPI_Pat16	HRAS.p.G13S		Investigate Actionability	1	MEL					Somatic variant	HRAS
MEL-IPI_Pat16	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat16	IL12RB1.p.F13L	Biologically Relevant		1	MEL					Somatic variant	IL12RB1
MEL-IPI_Pat16	KDR.p.G509E		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat16	KDR.p.N675K		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat16	MET.p.G578E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat16	NOTCH2.p.Y2470S		Biologically Relevant	1	MEL					Somatic variant	NOTCH2
MEL-IPI_Pat16	PTPN11.p.N277I	Investigate Actionability		1	MEL			Guideline		Somatic variant	PTPN11
MEL-IPI_Pat16	ROS1.p.G1025E	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat16	SLC45A3.p.G136S	Biologically Relevant		1	MEL					Somatic variant	SLC45A3
MEL-IPI_Pat16	TET2.p.S276F	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat16	TPX2.p.H335Y	Biologically Relevant		1	MEL					Somatic variant	TPX2
MEL-IPI_Pat16	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat160	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat160	COSMIC Signature 4	Investigate Actionability		1	MEL	Inferential				Mutational signature	COSMIC Signature 4
MEL-IPI_Pat160	ESR1.Deletion	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic copy number	ESR1 Del
MEL-IPI_Pat160	LIMK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Del
MEL-IPI_Pat160	NF2.Deletion		Investigate Actionability	1	MEL					Somatic copy number	NF2 Del
MEL-IPI_Pat160	NRAS.p.Q61R	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat160	ROS1.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat162	AKT3.p.L233LSplice_Site	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	AKT3
MEL-IPI_Pat162	APC.Deletion		Investigate Actionability	1	MEL					Somatic copy number	APC Del
MEL-IPI_Pat162	ATR.Deletion		Investigate Actionability	1	MEL					Somatic copy number	ATR Del
MEL-IPI_Pat162	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat162	ETV5.Deletion		Investigate Actionability	1	MEL					Somatic copy number	ETV5 Del
MEL-IPI_Pat162	EZH2.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	EZH2 Del
MEL-IPI_Pat162	FGFR2.Deletion		Investigate Actionability	1	MEL					Somatic copy number	FGFR2 Del
MEL-IPI_Pat162	HRAS.Deletion		Investigate Actionability	1	MEL					Somatic copy number	HRAS Del
MEL-IPI_Pat162	MIR17HG.Amplification	Putatively Actionable		1	MEL	Preclinical	Preclinical			Somatic copy number	MIR17HG Amp
MEL-IPI_Pat162	NF1.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	NF1 Del
MEL-IPI_Pat162	PIK3CA.Deletion		Investigate Actionability	1	MEL					Somatic copy number	PIK3CA Del
MEL-IPI_Pat162	RET.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	RET Del
MEL-IPI_Pat162	TP53.p.R175H	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat162	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat163	APC.Deletion		Investigate Actionability	1	MEL					Somatic copy number	APC Del
MEL-IPI_Pat163	ARID1A.p.V2046I	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat163	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat163	CD274.Deletion	Investigate Actionability		1	MEL	Inferential				Somatic copy number	CD274 Del
MEL-IPI_Pat163	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat163	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat163	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat163	JAK2.p.G164A	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	JAK2
MEL-IPI_Pat163	NTRK3.p.S261F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat163	ROS1.p.S283F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat163	TET2.p.P555fs	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat163	TP53.p.C238Y	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat163	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat165	ATM.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ATM Del
MEL-IPI_Pat165	CHEK1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK1 Del
MEL-IPI_Pat165	COSMIC Signature 18	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 18
MEL-IPI_Pat165	COSMIC Signature 5	Investigate Actionability		1	MEL	Inferential				Mutational signature	COSMIC Signature 5
MEL-IPI_Pat165	FGFR1.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR1 Del
MEL-IPI_Pat165	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat165	MITF.Amplification		Investigate Actionability	1	MEL					Somatic copy number	MITF Amp
MEL-IPI_Pat165	MLH3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	MLH3 Del
MEL-IPI_Pat165	NF1.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	NF1 Del
MEL-IPI_Pat165	NF1.p.E775*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat165	POLE.p.S988*	Investigate Actionability		1	MEL	Inferential		Clinical evidence		Somatic variant	POLE
MEL-IPI_Pat165	RUNX1.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL			Guideline		Somatic variant	RUNX1
MEL-IPI_Pat165	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat166	BLM.Amplification	Biologically Relevant		1	MEL					Somatic copy number	BLM Amp
MEL-IPI_Pat166	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat166	ERRFI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ERRFI1 Del
MEL-IPI_Pat166	IL12RB1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	IL12RB1 Del
MEL-IPI_Pat166	MITF.Amplification		Investigate Actionability	1	MEL					Somatic copy number	MITF Amp
MEL-IPI_Pat166	SF3B1.p.A277V	Investigate Actionability		1	MEL			Guideline		Somatic variant	SF3B1
MEL-IPI_Pat166	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat167	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat167	EML4.Deletion	Biologically Relevant		1	MEL					Somatic copy number	EML4 Del
MEL-IPI_Pat167	ERG.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	ERG Del
MEL-IPI_Pat167	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat167	PIK3CA.p.V71I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical		Clinical trial		Somatic variant	PIK3CA
MEL-IPI_Pat167	RAD51D.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RAD51D Del
MEL-IPI_Pat168	AKT1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	AKT1 Del
MEL-IPI_Pat168	ASXL1.p.G680S	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ASXL1
MEL-IPI_Pat168	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat168	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat168	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat168	ESRP1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ESRP1 Amp
MEL-IPI_Pat168	FGFR3.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	FGFR3 Del
MEL-IPI_Pat168	MET.Amplification	Putatively Actionable		1	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat168	MLH3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	MLH3 Del
MEL-IPI_Pat168	NFKBIA.Deletion		Investigate Actionability	1	MEL					Somatic copy number	NFKBIA Del
MEL-IPI_Pat168	NKX2-1.Deletion		Investigate Actionability	1	MEL					Somatic copy number	NKX2-1 Del
MEL-IPI_Pat168	NTRK3.p.K477N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat168	POLE2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	POLE2 Del
MEL-IPI_Pat168	TACC3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	TACC3 Del
MEL-IPI_Pat168	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat17	BRAF.Amplification	Putatively Actionable		1	MEL		Clinical evidence			Somatic copy number	BRAF Amp
MEL-IPI_Pat17	BRAF.p.600_601VK>E	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat17	BRD2.p.K402N		Biologically Relevant	1	MEL					Somatic variant	BRD2
MEL-IPI_Pat17	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat17	EZH2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	EZH2 Amp
MEL-IPI_Pat17	MET.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Guideline				Somatic variant	MET
MEL-IPI_Pat17	MSH6.p.S314G	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat17	PTEN.p.G129E	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MEL-IPI_Pat17	ROS1.p.K2N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat170	CD274.Deletion	Investigate Actionability		1	MEL	Inferential				Somatic copy number	CD274 Del
MEL-IPI_Pat170	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat170	EWSR1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	EWSR1 Amp
MEL-IPI_Pat170	FGFR1.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR1 Del
MEL-IPI_Pat170	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat170	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat170	NRAS.p.Q61L	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat170	RAD51D.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RAD51D Del
MEL-IPI_Pat170	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat170	TP53.p.Q317*	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Guideline		Somatic variant	TP53
MEL-IPI_Pat170	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat171	COSMIC Signature 3	Investigate Actionability		1	MEL	Inferential				Mutational signature	COSMIC Signature 3
MEL-IPI_Pat171	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat171	LIMK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Del
MEL-IPI_Pat171	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat174	AR.p.D696N	Investigate Actionability	Biologically Relevant	2	MEL		Clinical evidence			Somatic variant	AR
MEL-IPI_Pat174	ATM.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ATM Del
MEL-IPI_Pat174	ATR.p.L767F		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat174	BAP1.Deletion		Investigate Actionability	1	MEL					Somatic copy number	BAP1 Del
MEL-IPI_Pat174	BRD2.p.P299L		Biologically Relevant	1	MEL					Somatic variant	BRD2
MEL-IPI_Pat174	BRIP1.p.P949L	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat174	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat174	ERBB4.p.I658F		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat174	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat174	JAK3.p.M598I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	JAK3
MEL-IPI_Pat174	MET.Amplification	Putatively Actionable		1	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat174	MLH3.p.T1322S	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	MLH3
MEL-IPI_Pat174	MSH2.p.L469F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat174	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat174	TP53.p.Y236D	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat174	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat175	AKT3.Amplification	Biologically Relevant		1	MEL					Somatic copy number	AKT3 Amp
MEL-IPI_Pat175	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat175	CD274.Deletion	Investigate Actionability		1	MEL	Inferential				Somatic copy number	CD274 Del
MEL-IPI_Pat175	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat175	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat175	ESRP1.p.A122T	Biologically Relevant		1	MEL					Somatic variant	ESRP1
MEL-IPI_Pat175	EZH2.p.Y646H	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat175	JAK1.p.A419V	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat175	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat18	BRAF.p.Q562H	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat18	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat18	COSMIC Signature 18	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 18
MEL-IPI_Pat18	COSMIC Signature 20	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 20
MEL-IPI_Pat18	COSMIC Signature 6	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 6
MEL-IPI_Pat18	NRAS.p.F78S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat18	NRAS.p.R68G	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat18	RUNX1T1.p.H299P	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat18	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat19	COL1A1.p.K1033KSplice_Site	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat19	COL1A1.p.P535L	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat19	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat19	ERBB4.p.P1186L		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat19	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat19	GNAS.p.P268L		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat19	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat19	NOTCH2.p.L1236F		Biologically Relevant	1	MEL					Somatic variant	NOTCH2
MEL-IPI_Pat19	NRAS.Amplification	Biologically Relevant		1	MEL					Somatic copy number	NRAS Amp
MEL-IPI_Pat19	NRAS.p.Q61L	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat19	SETBP1.p.D1389N	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat19	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat21	ATM.p.N2326K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat21	BRCA2.p.P3320S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat21	COL1A1.Splice_Site	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat21	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat21	ERBB4.p.P778L		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat21	ERBB4.p.R114Q		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat21	ERG.p.G390E	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ERG
MEL-IPI_Pat21	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat21	LIMK2.p.P21L	Biologically Relevant		1	MEL					Somatic variant	LIMK2
MEL-IPI_Pat21	NF1.p.R440*	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat21	NFE2L2.p.E167K	Investigate Actionability		1	MEL		Preclinical			Somatic variant	NFE2L2
MEL-IPI_Pat21	NTRK3.p.P141L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat21	PDGFRA.p.G990D	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat21	POLD1.p.R343C	Investigate Actionability		1	MEL	Inferential		Clinical evidence		Somatic variant	POLD1
MEL-IPI_Pat21	RBM10.p.P74L	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	RBM10
MEL-IPI_Pat21	TET2.p.S1132F	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat24	CD274.Deletion	Investigate Actionability		1	MEL	Inferential				Somatic copy number	CD274 Del
MEL-IPI_Pat24	CHEK1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK1 Del
MEL-IPI_Pat24	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat24	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat24	JAK2.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat24	MYC.Amplification		Investigate Actionability	1	MEL					Somatic copy number	MYC Amp
MEL-IPI_Pat25	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat25	CDKN2A.p.L12P	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat25	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat25	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat25	MAP2K1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MAP2K1 Amp
MEL-IPI_Pat25	MITF.Amplification		Investigate Actionability	1	MEL					Somatic copy number	MITF Amp
MEL-IPI_Pat25	NTRK3.Amplification	Biologically Relevant		1	MEL					Somatic copy number	NTRK3 Amp
MEL-IPI_Pat25	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat27	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat27	CDK4.Amplification	Putatively Actionable		1	MEL	Guideline				Somatic copy number	CDK4 Amp
MEL-IPI_Pat27	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat27	ERBB3.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ERBB3 Amp
MEL-IPI_Pat27	POLE.Deletion	Biologically Relevant		1	MEL					Somatic copy number	POLE Del
MEL-IPI_Pat27	PTPN11.Deletion	Biologically Relevant		1	MEL					Somatic copy number	PTPN11 Del
MEL-IPI_Pat28	ALK.p.S295F	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat28	APC.p.P1176L		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat28	APC.p.T2760I		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat28	AR.p.L806P	Investigate Actionability	Biologically Relevant	2	MEL		Clinical evidence			Somatic variant	AR
MEL-IPI_Pat28	AURKA.p.G140D	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	AURKA
MEL-IPI_Pat28	BCOR.p.S91F	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BCOR
MEL-IPI_Pat28	BLM.p.G1228ESplice_Site	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BLM
MEL-IPI_Pat28	BLM.p.P355S	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BLM
MEL-IPI_Pat28	BLM.p.V524I	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BLM
MEL-IPI_Pat28	BRAF.p.S467L	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat28	BRCA1.p.A92V	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat28	BRCA1.p.S646N	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat28	BRCA2.p.R113K	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat28	BRCA2.p.S1871N	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat28	BRCA2.p.T3199I	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat28	BRCA2.p.V1790I	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat28	BRD2.p.G596D		Biologically Relevant	1	MEL					Somatic variant	BRD2
MEL-IPI_Pat28	BRD4.p.P1170S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	BRD4
MEL-IPI_Pat28	CCND3.p.A230T	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CCND3
MEL-IPI_Pat28	CD274.p.G119S	Biologically Relevant		1	MEL					Somatic variant	CD274
MEL-IPI_Pat28	CDK6.p.P199S		Biologically Relevant	1	MEL					Somatic variant	CDK6
MEL-IPI_Pat28	CDKN1A.p.S27N		Biologically Relevant	1	MEL					Somatic variant	CDKN1A
MEL-IPI_Pat28	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat28	CREBBP.p.A1100T		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat28	CRKL.p.P210S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CRKL
MEL-IPI_Pat28	EGFR.p.E27K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat28	EPHA5.p.G260D		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat28	ERCC2.p.G607R	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERCC2
MEL-IPI_Pat28	ERCC2.p.L397F	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERCC2
MEL-IPI_Pat28	ERCC2.p.W696*	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERCC2
MEL-IPI_Pat28	ERG.p.E116K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ERG
MEL-IPI_Pat28	ESRP1.p.E211K	Biologically Relevant		1	MEL					Somatic variant	ESRP1
MEL-IPI_Pat28	ETV4.p.P117S		Biologically Relevant	1	MEL					Somatic variant	ETV4
MEL-IPI_Pat28	EWSR1.p.T8I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	EWSR1
MEL-IPI_Pat28	EZH2.p.E197K	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat28	FBXW7.p.R505C	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat28	FGFR2.p.V680A	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat28	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat28	IL12RB1.p.P424S	Biologically Relevant		1	MEL					Somatic variant	IL12RB1
MEL-IPI_Pat28	JAK1.p.A17V	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat28	JAK1.p.E37K	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat28	JAK2.p.P197S	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	JAK2
MEL-IPI_Pat28	MLH3.p.M1006T	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	MLH3
MEL-IPI_Pat28	MSH2.p.G137D	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat28	MSH6.p.A794V	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat28	MSH6.p.S616F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat28	MTOR.p.L2261F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat28	NF1.Splice_Site	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat28	NF1.p.D1322N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat28	NF1.p.P2483L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat28	NF1.p.R1970K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat28	NF1.p.T737I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat28	NRAS.p.Q61R	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat28	NTRK3.p.V788I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NTRK3
MEL-IPI_Pat28	PBRM1.p.S1258F	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat28	PDGFRB.p.T232I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	PDGFRB
MEL-IPI_Pat28	PIK3CA.p.A995V	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical		Clinical trial		Somatic variant	PIK3CA
MEL-IPI_Pat28	PIK3CA.p.P449L	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical		Clinical trial		Somatic variant	PIK3CA
MEL-IPI_Pat28	PRPF8.p.E789K	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat28	PTCH1.p.D46N		Biologically Relevant	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat28	PTCH1.p.V763I		Investigate Actionability	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat28	RARA.p.A167T		Biologically Relevant	1	MEL					Somatic variant	RARA
MEL-IPI_Pat28	RB1.p.D701N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	RB1
MEL-IPI_Pat28	RBM10.p.G394D	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	RBM10
MEL-IPI_Pat28	RET.p.P996L	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	RET
MEL-IPI_Pat28	SETBP1.p.A1023V	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat28	SMARCA4.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical				Somatic variant	SMARCA4
MEL-IPI_Pat28	SMARCA4.p.Q1071*	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	SMARCA4
MEL-IPI_Pat28	TACC3.p.A686T	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat28	TACC3.p.V169M	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat28	TET2.p.L718F	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat28	TET2.p.S462N	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat28	TMPRSS2.p.D174N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	TMPRSS2
MEL-IPI_Pat28	TPX2.p.G26R	Biologically Relevant		1	MEL					Somatic variant	TPX2
MEL-IPI_Pat28	TSC1.p.E211K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat28	TSC2.p.W896*	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	TSC2
MEL-IPI_Pat28	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat28	XPO1.p.L897F		Biologically Relevant	1	MEL					Somatic variant	XPO1
MEL-IPI_Pat28	XPO1.p.R417H		Biologically Relevant	1	MEL					Somatic variant	XPO1
MEL-IPI_Pat28	ZRSR2.p.R452H	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	ZRSR2
MEL-IPI_Pat29	ALK.p.G1304E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat29	COL1A1.p.P1204L	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat29	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat29	CREBBP.p.R1800Q		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat29	ERG.p.S331N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ERG
MEL-IPI_Pat29	ETV5.p.P460L		Biologically Relevant	1	MEL					Somatic variant	ETV5
MEL-IPI_Pat29	ETV5.p.P460S		Biologically Relevant	1	MEL					Somatic variant	ETV5
MEL-IPI_Pat29	FLT3.p.E240K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat29	FLT3.p.G669E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat29	GNA11.p.V179G		Biologically Relevant	1	MEL					Somatic variant	GNA11
MEL-IPI_Pat29	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat29	IGF1R.p.P844L		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat29	IGF1R.p.P844S		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat29	ROS1.p.E1933K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat29	ROS1.p.E2120K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat29	SETBP1.p.K1203E	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat32	ABL1.p.S420F	Investigate Actionability	Biologically Relevant	2	MEL		Guideline			Somatic variant	ABL1
MEL-IPI_Pat32	AURKB.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	AURKB Del
MEL-IPI_Pat32	BRAF.Amplification	Putatively Actionable		1	MEL		Clinical evidence			Somatic copy number	BRAF Amp
MEL-IPI_Pat32	BRAF.p.599_599T>TT	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat32	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat32	CREBBP.p.S2356F		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat32	ERBB4.p.E452K		Investigate Actionability	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat32	ERBB4.p.H470Y		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat32	ESRP1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ESRP1 Amp
MEL-IPI_Pat32	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat32	MCL1.p.R95K		Biologically Relevant	1	MEL					Somatic variant	MCL1
MEL-IPI_Pat32	MYC.Amplification	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	MYC Amp
MEL-IPI_Pat32	TSC2.p.T1154I	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat32	TSC2.p.T1154S	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat33	COL1A1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	COL1A1 Amp
MEL-IPI_Pat33	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat33	CTNNB1.p.D32N	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	CTNNB1
MEL-IPI_Pat33	ERBB4.p.G702D		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat33	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat33	MDM4.p.P315S		Biologically Relevant	1	MEL					Somatic variant	MDM4
MEL-IPI_Pat33	NF1.p.E470*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat33	NF1.p.R1362*	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat33	NF2.Splice_Site		Investigate Actionability	1	MEL					Somatic variant	NF2
MEL-IPI_Pat33	PDGFRA.p.E996K	Investigate Actionability	Investigate Actionability	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat33	PDGFRA.p.S880F	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat33	TSC2.p.D635N	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat33	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat36	BRAF.Amplification	Putatively Actionable		1	MEL		Clinical evidence			Somatic copy number	BRAF Amp
MEL-IPI_Pat36	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat36	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat36	EGFR.p.V741M	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat36	RB1.p.R579*	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	RB1
MEL-IPI_Pat36	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat37	ARID1A.Splice_Site	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat37	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat37	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat37	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat37	JAK1.p.G182E	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	JAK1
MEL-IPI_Pat37	LIMK2--HCCS	Biologically Relevant		1	MEL					Rearrangement	LIMK2--HCCS
MEL-IPI_Pat37	MET.p.G667S	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat37	PBRM1.p.S660N	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat37	PIK3CB.p.N553S	Investigate Actionability		1	MEL	Preclinical				Somatic variant	PIK3CB
MEL-IPI_Pat37	PIK3R1.p.G12V		Biologically Relevant	1	MEL					Somatic variant	PIK3R1
MEL-IPI_Pat37	PMS2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PMS2 Amp
MEL-IPI_Pat37	RB1.Deletion	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	RB1 Del
MEL-IPI_Pat37	RET.Amplification	Biologically Relevant		1	MEL					Somatic copy number	RET Amp
MEL-IPI_Pat37	SMO.p.R291Q		Biologically Relevant	1	MEL					Somatic variant	SMO
MEL-IPI_Pat37	TMPRSS2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	TMPRSS2 Amp
MEL-IPI_Pat37	TP53.p.S215R	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat37	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat38	ABL1.p.P684L	Investigate Actionability	Biologically Relevant	2	MEL		Guideline			Somatic variant	ABL1
MEL-IPI_Pat38	APC.p.R1273K		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat38	ARAF.p.L531F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ARAF
MEL-IPI_Pat38	ARID1A.p.A656V	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat38	ATM.p.G197E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat38	ATM.p.P2907S	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat38	BARD1.Splice_Site	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	BARD1
MEL-IPI_Pat38	BCL2.p.A43V		Investigate Actionability	1	MEL					Somatic variant	BCL2
MEL-IPI_Pat38	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat38	BRCA1.p.A1369T	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat38	BRIP1.p.T166I	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat38	CHEK1.p.G16E	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	CHEK1
MEL-IPI_Pat38	COL1A1--SPTBN1	Investigate Actionability		1	MEL	Guideline				Rearrangement	COL1A1--SPTBN1
MEL-IPI_Pat38	COL1A1.p.V62I	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat38	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat38	CTNNB1.p.T41N	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	CTNNB1
MEL-IPI_Pat38	EGFR.p.L770F	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat38	ERCC2.p.V242I	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERCC2
MEL-IPI_Pat38	ERRFI1.p.K42KSplice_Site	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERRFI1
MEL-IPI_Pat38	ETV6.p.A215T	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ETV6
MEL-IPI_Pat38	EZH2.p.C558YSplice_Site	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat38	FBXW7.p.G644E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat38	FBXW7.p.G687E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat38	FGFR1.p.A579T	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR1
MEL-IPI_Pat38	FGFR3.p.E588K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	FGFR3
MEL-IPI_Pat38	FGFR3.p.G668E	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	FGFR3
MEL-IPI_Pat38	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat38	IGF1R.p.L125F		Biologically Relevant	1	MEL					Somatic variant	IGF1R
MEL-IPI_Pat38	JAK3.p.R451*	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	JAK3
MEL-IPI_Pat38	MSH6.p.G1157D	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat38	MSH6.p.L147F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat38	MTOR.p.T1346I	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat38	NF1.p.A1098V	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat38	NTRK1.p.G368D	Biologically Relevant		1	MEL					Somatic variant	NTRK1
MEL-IPI_Pat38	PAK1.p.P15L	Biologically Relevant		1	MEL					Somatic variant	PAK1
MEL-IPI_Pat38	PBRM1.p.A750V	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat38	PDGFRB.p.G997D	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	PDGFRB
MEL-IPI_Pat38	PIK3CA.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved		Clinical trial		Somatic variant	PIK3CA
MEL-IPI_Pat38	PIK3R1.p.G13R		Biologically Relevant	1	MEL					Somatic variant	PIK3R1
MEL-IPI_Pat38	POT1.p.T217I	Biologically Relevant		1	MEL					Somatic variant	POT1
MEL-IPI_Pat38	PTCH1.p.G110E		Biologically Relevant	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat38	PTCH1.p.P1262L		Biologically Relevant	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat38	PTEN.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MEL-IPI_Pat38	PTPN11.p.P107L	Investigate Actionability		1	MEL			Guideline		Somatic variant	PTPN11
MEL-IPI_Pat38	RARA.p.P23L		Biologically Relevant	1	MEL					Somatic variant	RARA
MEL-IPI_Pat38	RB1.p.G581R	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	RB1
MEL-IPI_Pat38	SETBP1.p.G588R	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat38	SLC45A3.p.R245Q	Biologically Relevant		1	MEL					Somatic variant	SLC45A3
MEL-IPI_Pat38	TSC1.p.G94D	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat39	ALK.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ALK Amp
MEL-IPI_Pat39	BCR.p.K795fs	Investigate Actionability		1	MEL		Clinical evidence			Somatic variant	BCR
MEL-IPI_Pat39	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat39	COL1A1--RN7SKP71	Investigate Actionability		1	MEL	Guideline				Rearrangement	COL1A1--RN7SKP71
MEL-IPI_Pat39	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat39	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat39	CTNNB1--MALAT1	Biologically Relevant		1	MEL					Rearrangement	CTNNB1--MALAT1
MEL-IPI_Pat39	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat39	JAK3--URB1	Biologically Relevant		1	MEL					Rearrangement	JAK3--URB1
MEL-IPI_Pat39	KDR.p.P1128R		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat39	PDGFRB.Deletion	Biologically Relevant		1	MEL					Somatic copy number	PDGFRB Del
MEL-IPI_Pat39	TP53.p.R273C	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat40	COSMIC Signature 16	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 16
MEL-IPI_Pat40	COSMIC Signature 2	Investigate Actionability		1	MEL	Inferential				Mutational signature	COSMIC Signature 2
MEL-IPI_Pat40	COSMIC Signature 23	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 23
MEL-IPI_Pat40	ERBB3--MALAT1	Biologically Relevant		1	MEL					Rearrangement	ERBB3--MALAT1
MEL-IPI_Pat40	MET.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat40	POT1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	POT1 Amp
MEL-IPI_Pat40	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat41	ALK.p.E314K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat41	CD274.Deletion	Investigate Actionability		1	MEL	Inferential				Somatic copy number	CD274 Del
MEL-IPI_Pat41	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat41	CTNNB1.p.W383C	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	CTNNB1
MEL-IPI_Pat41	ETV4.p.R148W		Biologically Relevant	1	MEL					Somatic variant	ETV4
MEL-IPI_Pat41	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat41	FLT3.p.E204K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat41	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat41	PDGFRA.p.G430E	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat41	RUNX1T1.p.E250K	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat43	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat43	BRCA2.p.N2266S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat43	BRCA2.p.V950A	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat43	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat43	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat43	ERG.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ERG Del
MEL-IPI_Pat43	ESRP1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ESRP1 Amp
MEL-IPI_Pat43	FGFR1.Amplification	Putatively Actionable		1	MEL	Preclinical				Somatic copy number	FGFR1 Amp
MEL-IPI_Pat43	HLA-B--SF3B1	Biologically Relevant		1	MEL					Rearrangement	HLA-B--SF3B1
MEL-IPI_Pat43	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat43	RPL9--COL1A1	Investigate Actionability		1	MEL	Guideline				Rearrangement	RPL9--COL1A1
MEL-IPI_Pat43	TTN--COL1A1	Investigate Actionability		1	MEL	Guideline				Rearrangement	TTN--COL1A1
MEL-IPI_Pat43	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat44	AKT1.p.Y112H	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	AKT1
MEL-IPI_Pat44	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat44	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat44	MYC.Amplification	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	MYC Amp
MEL-IPI_Pat44	NRAS.p.Q61L	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat44	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat44	ROS1.p.D1538N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat45	ASXL1.p.L1170fs	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ASXL1
MEL-IPI_Pat45	ATM.p.R805Q	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat45	AURKB.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	AURKB Del
MEL-IPI_Pat45	BCR.p.P523LSplice_Site	Investigate Actionability		1	MEL		Clinical evidence			Somatic variant	BCR
MEL-IPI_Pat45	BRCA2.p.L1103S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat45	CDKN2A.p.A67V	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat45	COL1A1.p.R802C	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat45	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat45	EPHA5.p.R541*		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat45	EPHA5.p.T176A		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat45	ERBB2.p.G408DSplice_Site	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	ERBB2
MEL-IPI_Pat45	ERBB4.p.P1092S		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat45	FBXW7.p.R222*	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat45	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat45	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat45	ROS1.p.Q2212*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat45	STAG2.p.R146L	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	STAG2
MEL-IPI_Pat45	SYK.p.E614K		Biologically Relevant	1	MEL					Somatic variant	SYK
MEL-IPI_Pat45	TP53.Deletion	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	TP53 Del
MEL-IPI_Pat45	TP53.p.S241F	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat45	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat46	ARAF.p.P185H	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ARAF
MEL-IPI_Pat46	ARID1A.p.Q588*	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat46	CHEK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK2 Del
MEL-IPI_Pat46	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat46	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat46	CRKL.Amplification	Putatively Actionable		1	MEL		Clinical evidence			Somatic copy number	CRKL Amp
MEL-IPI_Pat46	EWSR1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	EWSR1 Del
MEL-IPI_Pat46	LIMK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Del
MEL-IPI_Pat46	PDGFB.Deletion	Biologically Relevant		1	MEL					Somatic copy number	PDGFB Del
MEL-IPI_Pat46	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat47	ATR.p.R989C		Investigate Actionability	1	MEL					Somatic variant	ATR
MEL-IPI_Pat47	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat47	FGFR1.p.P25L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR1
MEL-IPI_Pat47	FGFR2.p.E596V	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat47	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat49	AKT3.p.S197N	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	AKT3
MEL-IPI_Pat49	ALK.p.D951N	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat49	ATM--CTSD	Biologically Relevant		1	MEL					Rearrangement	ATM--CTSD
MEL-IPI_Pat49	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat49	BRAF.p.V600M	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat49	CDKN2A.p.E37*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat49	CHEK1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK1 Del
MEL-IPI_Pat49	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat49	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat49	KDR.p.D1056N		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat49	MAP2K1.p.P124S	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic variant	MAP2K1
MEL-IPI_Pat49	MYC.p.56_57insV	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MYC
MEL-IPI_Pat49	NOTCH1.p.T1725I		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat49	PTCH1.p.H1413Y		Biologically Relevant	1	MEL					Somatic variant	PTCH1
MEL-IPI_Pat49	PTEN.p.K263*	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MEL-IPI_Pat49	RB1.p.P796S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	RB1
MEL-IPI_Pat49	RET.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RET Del
MEL-IPI_Pat49	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat49	SMARCA4.p.R726H	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	SMARCA4
MEL-IPI_Pat49	TSC2.p.R917W	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat50	ALK.p.R1284K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat50	AURKB.p.R283C	Biologically Relevant		1	MEL					Somatic variant	AURKB
MEL-IPI_Pat50	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat50	BRAF.p.V600M	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat50	BRCA2.p.Q2561*	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat50	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat50	CTNNB1--MALAT1	Biologically Relevant		1	MEL					Rearrangement	CTNNB1--MALAT1
MEL-IPI_Pat50	FTH1--RAF1	Investigate Actionability		1	MEL	Preclinical				Rearrangement	FTH1--RAF1
MEL-IPI_Pat50	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat50	MC1R.Deletion	Biologically Relevant		1	MEL					Somatic copy number	MC1R Del
MEL-IPI_Pat50	NF1.p.P228S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat50	NRAS.Deletion	Biologically Relevant		1	MEL					Somatic copy number	NRAS Del
MEL-IPI_Pat50	PIGN--PMS2	Biologically Relevant		1	MEL					Rearrangement	PIGN--PMS2
MEL-IPI_Pat50	PRPF8.p.T1025K	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat50	PTEN.p.T277I	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MEL-IPI_Pat50	RAD51D.p.S144F	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	RAD51D
MEL-IPI_Pat50	ZMYM4--MSH2	Biologically Relevant		1	MEL					Rearrangement	ZMYM4--MSH2
MEL-IPI_Pat54	AKT1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	AKT1 Del
MEL-IPI_Pat54	APC.p.P1733S		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat54	ATR.p.K2311Q		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat54	AURKB.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	AURKB Del
MEL-IPI_Pat54	CCND1.Amplification	Putatively Actionable		1	MEL	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
MEL-IPI_Pat54	CD274.Deletion	Investigate Actionability		1	MEL	Inferential				Somatic copy number	CD274 Del
MEL-IPI_Pat54	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat54	CTNNB1.p.S37F	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	CTNNB1
MEL-IPI_Pat54	GNAS.p.S192L		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat54	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat54	JAK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat54	KDR.p.G550D		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat54	MSH6.p.R515K	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat54	NRAS.p.Q61L	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat54	PDGFRA.p.P519S	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat54	PDGFRA.p.R764C	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat54	PRPF8.Deletion	Biologically Relevant		1	MEL					Somatic copy number	PRPF8 Del
MEL-IPI_Pat54	RUNX1.p.L317F	Investigate Actionability	Biologically Relevant	2	MEL			Guideline		Somatic variant	RUNX1
MEL-IPI_Pat54	STK11.p.Q364*		Biologically Relevant	1	MEL					Somatic variant	STK11
MEL-IPI_Pat54	TP53.Deletion	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	TP53 Del
MEL-IPI_Pat55	BRAF.p.G466E	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat55	CCND1.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
MEL-IPI_Pat55	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat55	ERBB2.p.G287R	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB2
MEL-IPI_Pat55	FLT3.p.W854*	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat55	GNAS.p.P411L		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat55	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat55	NF1.Splice_Site	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat55	NF1.p.R1870QSplice_Site	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat55	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat56	CCND1.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
MEL-IPI_Pat56	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat56	ESR1.Deletion	Investigate Actionability		1	MEL			Clinical evidence		Somatic copy number	ESR1 Del
MEL-IPI_Pat56	ESRP1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ESRP1 Amp
MEL-IPI_Pat56	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat56	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat56	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat57	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat57	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat57	ESR1.Deletion	Investigate Actionability		1	MEL			Clinical evidence		Somatic copy number	ESR1 Del
MEL-IPI_Pat57	GATA3.Amplification	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Amp
MEL-IPI_Pat57	MTOR.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MTOR Amp
MEL-IPI_Pat57	SLC45A3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	SLC45A3 Del
MEL-IPI_Pat57	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat58	APC.p.R213*		Investigate Actionability	1	MEL					Somatic variant	APC
MEL-IPI_Pat58	AR.p.G628R	Investigate Actionability	Biologically Relevant	2	MEL		Clinical evidence			Somatic variant	AR
MEL-IPI_Pat58	ASXL1.p.S203F	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	ASXL1
MEL-IPI_Pat58	ATM.p.A188T	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat58	ATM.p.E2366K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat58	ATM.p.G696R	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat58	ATM.p.P2353L	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat58	ATR.p.S115F		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat58	BCOR.p.S879N	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BCOR
MEL-IPI_Pat58	BRAF.p.T411I	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat58	BRCA1.p.V932I	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
MEL-IPI_Pat58	CDH1.p.T115M		Biologically Relevant	1	MEL					Somatic variant	CDH1
MEL-IPI_Pat58	CDK4.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Guideline				Somatic copy number	CDK4 Amp
MEL-IPI_Pat58	CHEK1.p.P188S	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	CHEK1
MEL-IPI_Pat58	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat58	DDR2.p.V603I		Biologically Relevant	1	MEL					Somatic variant	DDR2
MEL-IPI_Pat58	EGFR.p.M942I	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat58	EPHA5.p.T773I		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat58	ERBB2.p.V1018M	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB2
MEL-IPI_Pat58	ERBB3.p.E555K	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat58	ERBB3.p.R453H	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat58	ERBB4.p.D489N		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat58	ERRFI1.p.G27E	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERRFI1
MEL-IPI_Pat58	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat58	IL12RB1.p.D145N	Biologically Relevant		1	MEL					Somatic variant	IL12RB1
MEL-IPI_Pat58	KDR.p.S576F		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat58	KIT.p.D816N	Investigate Actionability	Investigate Actionability	2	MEL	Guideline		Guideline		Somatic variant	KIT
MEL-IPI_Pat58	KIT.p.K642E	Putatively Actionable	Investigate Actionability	2	MEL	Guideline		Guideline		Somatic variant	KIT
MEL-IPI_Pat58	LIMK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Del
MEL-IPI_Pat58	LIMK2.p.P569L	Biologically Relevant		1	MEL					Somatic variant	LIMK2
MEL-IPI_Pat58	MDM2.Amplification		Investigate Actionability	1	MEL					Somatic copy number	MDM2 Amp
MEL-IPI_Pat58	MDM2.p.G62D	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MDM2
MEL-IPI_Pat58	MLH3.p.T326I	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	MLH3
MEL-IPI_Pat58	MPL.p.V368M	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MPL
MEL-IPI_Pat58	MSH2.p.G587SSplice_Site	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat58	MSH2.p.P507S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat58	MSH6.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat58	MSH6.p.G1134E	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat58	MSH6.p.G1157D	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat58	MSH6.p.P408L	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat58	MSH6.p.Q1258*	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat58	MSH6.p.S1141F	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat58	MSH6.p.T1219I	Investigate Actionability	Investigate Actionability	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat58	MTOR.p.E1427K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat58	NF1.Splice_Site	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat58	NF1.p.G875D	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat58	NOTCH1.p.H2378Y		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat58	NOTCH2.p.A1920T		Biologically Relevant	1	MEL					Somatic variant	NOTCH2
MEL-IPI_Pat58	PIK3CA.p.S323F	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical		Clinical trial		Somatic variant	PIK3CA
MEL-IPI_Pat58	POLE2.p.G373D	Biologically Relevant		1	MEL					Somatic variant	POLE2
MEL-IPI_Pat58	PRPF8.p.E2322K	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat58	PRPF8.p.Q2038*	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat58	RARA.p.A216V		Biologically Relevant	1	MEL					Somatic variant	RARA
MEL-IPI_Pat58	RET.Deletion	Biologically Relevant		1	MEL					Somatic copy number	RET Del
MEL-IPI_Pat58	ROS1.p.A1907T	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat58	ROS1.p.Q2175*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat58	SF3B1.p.T7I	Investigate Actionability		1	MEL			Guideline		Somatic variant	SF3B1
MEL-IPI_Pat58	TPX2.p.S174N	Biologically Relevant		1	MEL					Somatic variant	TPX2
MEL-IPI_Pat58	TSC2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	TSC2 Del
MEL-IPI_Pat58	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat59	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat59	GNAS.p.R187C		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat59	PDGFRA.p.E141K	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	PDGFRA
MEL-IPI_Pat60	AKT1.p.Q79K	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical				Somatic variant	AKT1
MEL-IPI_Pat60	ALK.p.S1561L	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat60	BLM.p.M951I	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BLM
MEL-IPI_Pat60	BRAF.p.600_601VK>E	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat60	CDKN1B.p.TSCIS185del		Biologically Relevant	1	MEL					Somatic variant	CDKN1B
MEL-IPI_Pat60	CHEK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK2 Del
MEL-IPI_Pat60	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat60	ESR1.p.R412RSplice_Site	Investigate Actionability	Biologically Relevant	2	MEL		Clinical evidence			Somatic variant	ESR1
MEL-IPI_Pat60	EWSR1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	EWSR1 Del
MEL-IPI_Pat60	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat60	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat60	KDR.p.L643F		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat60	LIMK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Del
MEL-IPI_Pat60	PMS2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PMS2 Amp
MEL-IPI_Pat60	ROS1.p.D735N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat60	SYK.p.S567F		Biologically Relevant	1	MEL					Somatic variant	SYK
MEL-IPI_Pat60	TET2.p.Q652*	Investigate Actionability	Biologically Relevant	2	MEL	Guideline				Somatic variant	TET2
MEL-IPI_Pat62	ARID1A.p.P690S	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat62	ATR.p.A2181T		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat62	AURKB.p.E174K	Biologically Relevant		1	MEL					Somatic variant	AURKB
MEL-IPI_Pat62	CHEK2.p.A502TSplice_Site	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	CHEK2
MEL-IPI_Pat62	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat62	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat62	ERBB3.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat62	ERBB4.p.E1167K		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat62	FBXW7.p.L648I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat62	GNAS.p.G153E		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat62	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat62	KDR.p.D639N		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat62	KDR.p.G493R		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat62	MCL1.p.V258L		Biologically Relevant	1	MEL					Somatic variant	MCL1
MEL-IPI_Pat62	MSH6.p.-524fs	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH6
MEL-IPI_Pat62	NF1.p.L1975F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat62	NF1.p.Q1070*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat62	NKX2-1.p.M216I		Biologically Relevant	1	MEL					Somatic variant	NKX2-1
MEL-IPI_Pat62	NTRK1.p.G344E	Biologically Relevant		1	MEL					Somatic variant	NTRK1
MEL-IPI_Pat62	PALB2.p.L698F	Investigate Actionability		1	MEL	Clinical evidence		Inferential		Somatic variant	PALB2
MEL-IPI_Pat62	ROS1.p.A651V	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat62	ROS1.p.D1202N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat62	TSC1.p.P684L	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC1
MEL-IPI_Pat62	WT1.p.R222C		Biologically Relevant	1	MEL					Somatic variant	WT1
MEL-IPI_Pat62	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat63	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat63	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat63	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat63	MLH3.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MLH3 Amp
MEL-IPI_Pat63	MTOR.Amplification	Biologically Relevant		1	MEL					Somatic copy number	MTOR Amp
MEL-IPI_Pat63	NOTCH1.p.E2309*		Biologically Relevant	1	MEL					Somatic variant	NOTCH1
MEL-IPI_Pat63	NRAS.p.Q61R	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat63	PRPF8.Deletion	Biologically Relevant		1	MEL					Somatic copy number	PRPF8 Del
MEL-IPI_Pat64	ARID1A.p.M1273I	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat64	AURKB.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	AURKB Del
MEL-IPI_Pat64	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat64	CCND1.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
MEL-IPI_Pat64	CD274.Deletion	Investigate Actionability		1	MEL	Inferential				Somatic copy number	CD274 Del
MEL-IPI_Pat64	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat64	CREBBP.p.D1508A		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat64	ERBB4.p.L698*		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat64	EZH2.p.Y646S	Investigate Actionability	Investigate Actionability	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat64	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat64	GNAS.p.D19N		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat64	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat64	JAK2.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	JAK2 Del
MEL-IPI_Pat64	NRAS.p.Q61L	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat64	PAK1.Deletion	Investigate Actionability		1	MEL			Clinical evidence		Somatic copy number	PAK1 Del
MEL-IPI_Pat64	RUNX1T1.p.H166Y	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat64	TP53.Deletion	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	TP53 Del
MEL-IPI_Pat64	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat66	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat66	EPHA3.p.S548L		Biologically Relevant	1	MEL					Somatic variant	EPHA3
MEL-IPI_Pat66	EPHA5.p.V743M		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat66	ERBB4.p.G918E		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat66	ERBB4.p.P263L		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat66	ERG.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	ERG Del
MEL-IPI_Pat66	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat66	MAP2K1.p.F53I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	MAP2K1
MEL-IPI_Pat66	NF2.p.W258*		Investigate Actionability	1	MEL					Somatic variant	NF2
MEL-IPI_Pat66	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat67	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat67	KRAS.Amplification	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	KRAS Amp
MEL-IPI_Pat67	KRAS.p.Q61H	Investigate Actionability	Putatively Actionable	2	MEL	Clinical trial	Clinical trial	Clinical evidence		Somatic variant	KRAS
MEL-IPI_Pat67	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat70	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat70	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat70	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat70	PBRM1.p.R1566W	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat70	ROS1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ROS1 Del
MEL-IPI_Pat71	ATR.p.S670T		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat71	COL1A1.p.G383S	Biologically Relevant		1	MEL					Somatic variant	COL1A1
MEL-IPI_Pat71	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat71	ERBB4.p.R78QSplice_Site		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat71	ERBB4.p.R842W		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat71	ERRFI1.p.E51K	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	ERRFI1
MEL-IPI_Pat71	ESRP1.p.A337T	Biologically Relevant		1	MEL					Somatic variant	ESRP1
MEL-IPI_Pat71	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat71	MPL.p.S414L	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MPL
MEL-IPI_Pat71	NRAS.p.Q61R	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat71	RUNX1T1.p.R533Q	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat71	TP53.p.Q331*	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Guideline		Somatic variant	TP53
MEL-IPI_Pat73	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat73	MLH1.Amplification	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	MLH1 Amp
MEL-IPI_Pat73	MSH2.p.P476L	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	MSH2
MEL-IPI_Pat73	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat73	ROS1.p.R2126W	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat73	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat74	ALK.p.M1615I	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat74	CCND1.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
MEL-IPI_Pat74	CHEK2.p.A17V	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	CHEK2
MEL-IPI_Pat74	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat74	EPHA5.p.E665K		Biologically Relevant	1	MEL					Somatic variant	EPHA5
MEL-IPI_Pat74	ERBB4.p.K1223N		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat74	EZH2.p.N366S	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat74	EZH2.p.P527L	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	EZH2
MEL-IPI_Pat74	FGFR1.Deletion	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	FGFR1 Del
MEL-IPI_Pat74	FGFR3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FGFR3 Del
MEL-IPI_Pat74	FLCN.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLCN Del
MEL-IPI_Pat74	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat74	FLI1.p.A125T	Biologically Relevant		1	MEL					Somatic variant	FLI1
MEL-IPI_Pat74	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat74	MPL.p.S268F	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MPL
MEL-IPI_Pat74	NRAS.p.Q61R	Putatively Actionable	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat74	PAK1.Deletion	Investigate Actionability		1	MEL			Clinical evidence		Somatic copy number	PAK1 Del
MEL-IPI_Pat74	PRPF8.Deletion	Biologically Relevant		1	MEL					Somatic copy number	PRPF8 Del
MEL-IPI_Pat74	ROS1.p.D1854N	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat74	SETBP1.p.P563L	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat74	TACC3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	TACC3 Del
MEL-IPI_Pat74	TP53.Deletion	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	TP53 Del
MEL-IPI_Pat74	TP53.p.R213*	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Guideline		Somatic variant	TP53
MEL-IPI_Pat74	TSC1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	TSC1 Del
MEL-IPI_Pat74	TSC2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	TSC2 Del
MEL-IPI_Pat76	BCR.Deletion	Biologically Relevant		1	MEL					Somatic copy number	BCR Del
MEL-IPI_Pat76	CHEK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	CHEK2 Del
MEL-IPI_Pat76	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat76	ERBB3.p.G807E	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence				Somatic variant	ERBB3
MEL-IPI_Pat76	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat76	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat76	LIMK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Del
MEL-IPI_Pat76	MET.Amplification	Putatively Actionable		1	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat76	PTEN.Deletion	Putatively Actionable		1	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat76	SMAD2.p.S397F		Biologically Relevant	1	MEL					Somatic variant	SMAD2
MEL-IPI_Pat76	WT1.p.G139R		Biologically Relevant	1	MEL					Somatic variant	WT1
MEL-IPI_Pat77	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat77	CDKN2A.p.RVAEL7fs	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CDKN2A
MEL-IPI_Pat77	COL1A1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	COL1A1 Amp
MEL-IPI_Pat77	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat77	FGFR2.p.S569F	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat77	MAP2K1.p.L177M	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	MAP2K1
MEL-IPI_Pat77	NF2.p.G43W		Biologically Relevant	1	MEL					Somatic variant	NF2
MEL-IPI_Pat77	PTPN11.p.Q347*	Investigate Actionability		1	MEL			Guideline		Somatic variant	PTPN11
MEL-IPI_Pat77	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat78	ATM.p.P1829R	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	ATM
MEL-IPI_Pat78	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat78	COSMIC Signature 19	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 19
MEL-IPI_Pat78	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat78	NRAS.Deletion	Biologically Relevant		1	MEL					Somatic copy number	NRAS Del
MEL-IPI_Pat79	CCND1.Amplification	Putatively Actionable		1	MEL	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
MEL-IPI_Pat79	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat79	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat79	LIMK2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	LIMK2 Amp
MEL-IPI_Pat79	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat79	NTRK2.Deletion	Biologically Relevant		1	MEL					Somatic copy number	NTRK2 Del
MEL-IPI_Pat79	PIK3R1.p.P196L		Biologically Relevant	1	MEL					Somatic variant	PIK3R1
MEL-IPI_Pat79	PMS2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PMS2 Amp
MEL-IPI_Pat79	RET.p.P953S	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	RET
MEL-IPI_Pat80	BRAF.Amplification	Putatively Actionable		1	MEL		Clinical evidence			Somatic copy number	BRAF Amp
MEL-IPI_Pat80	BRAF.p.E611*	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat80	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat80	COSMIC Signature 11	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 11
MEL-IPI_Pat80	CRKL.p.N302S	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CRKL
MEL-IPI_Pat80	CRKL.p.V247A	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CRKL
MEL-IPI_Pat80	MYC.Amplification	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	MYC Amp
MEL-IPI_Pat80	RELT--EML4	Investigate Actionability		1	MEL	Guideline				Rearrangement	RELT--EML4
MEL-IPI_Pat80	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat81	BRAF.p.D594Y	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat81	BRAF.p.E611*	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat81	CDK4.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Guideline				Somatic copy number	CDK4 Amp
MEL-IPI_Pat81	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat81	COSMIC Signature 4	Investigate Actionability		1	MEL	Inferential				Mutational signature	COSMIC Signature 4
MEL-IPI_Pat81	MDM2.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	MDM2 Amp
MEL-IPI_Pat81	MTOR.p.A400D	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat81	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat82	BRAF.Splice_Site	Investigate Actionability	Investigate Actionability	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat82	BRAF.p.D594Y	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat82	BRAF.p.E611*	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat82	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat82	BRD2.p.T150S		Biologically Relevant	1	MEL					Somatic variant	BRD2
MEL-IPI_Pat82	CCNE1.p.P271L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	CCNE1
MEL-IPI_Pat82	CD274.Amplification	Putatively Actionable		1	MEL	Inferential				Somatic copy number	CD274 Amp
MEL-IPI_Pat82	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat82	DNMT3A.p.P41L	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	DNMT3A
MEL-IPI_Pat82	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat82	JAK2.Amplification	Biologically Relevant		1	MEL					Somatic copy number	JAK2 Amp
MEL-IPI_Pat82	JAK3.p.S622N	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	JAK3
MEL-IPI_Pat82	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat83	BAP1.p.H169del		Biologically Relevant	1	MEL					Somatic variant	BAP1
MEL-IPI_Pat83	CDKN1B.Deletion		Investigate Actionability	1	MEL					Somatic copy number	CDKN1B Del
MEL-IPI_Pat83	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat83	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat83	DNMT3A.p.V176M	Investigate Actionability	Biologically Relevant	2	MEL			Clinical evidence		Somatic variant	DNMT3A
MEL-IPI_Pat83	ESRP1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ESRP1 Amp
MEL-IPI_Pat83	GNA11.p.Q209L		Investigate Actionability	1	MEL					Somatic variant	GNA11
MEL-IPI_Pat83	MYC.Amplification	Putatively Actionable		1	MEL			Clinical evidence		Somatic copy number	MYC Amp
MEL-IPI_Pat83	RUNX1T1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	RUNX1T1 Amp
MEL-IPI_Pat85	ABL1.p.S162F	Investigate Actionability	Biologically Relevant	2	MEL		Guideline			Somatic variant	ABL1
MEL-IPI_Pat85	ARID1A.p.Q581*	Investigate Actionability		1	MEL	Preclinical		Clinical evidence		Somatic variant	ARID1A
MEL-IPI_Pat85	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat85	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat85	NF1.Splice_Site	Biologically Relevant	Investigate Actionability	2	MEL					Somatic variant	NF1
MEL-IPI_Pat85	NF1.p.L90Q	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat85	NF2.p.R341*		Investigate Actionability	1	MEL					Somatic variant	NF2
MEL-IPI_Pat85	NFE2L2.p.V579A	Investigate Actionability		1	MEL		Preclinical			Somatic variant	NFE2L2
MEL-IPI_Pat85	NOTCH2.p.A2448V		Biologically Relevant	1	MEL					Somatic variant	NOTCH2
MEL-IPI_Pat85	NTRK1.p.D270N	Biologically Relevant		1	MEL					Somatic variant	NTRK1
MEL-IPI_Pat85	TP53.p.S46Y	Investigate Actionability	Biologically Relevant	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat85	TPX2.p.Q275*	Biologically Relevant		1	MEL					Somatic variant	TPX2
MEL-IPI_Pat86	APC.p.P1361S		Biologically Relevant	1	MEL					Somatic variant	APC
MEL-IPI_Pat86	BRAF.p.E611*	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat86	BRAF.p.H585N	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat86	BRAF.p.L597I	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat86	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat86	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat86	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat86	MET.Amplification	Putatively Actionable		1	MEL	Guideline	Guideline			Somatic copy number	MET Amp
MEL-IPI_Pat86	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MEL-IPI_Pat86	TSC2.p.E138K	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat88	ALK.p.G818R	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Preclinical			Somatic variant	ALK
MEL-IPI_Pat88	ATR.p.H664Y		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat88	ATR.p.P2287L		Biologically Relevant	1	MEL					Somatic variant	ATR
MEL-IPI_Pat88	BARD1.Splice_Site	Investigate Actionability		1	MEL	Inferential		Inferential		Somatic variant	BARD1
MEL-IPI_Pat88	BRAF.p.P632S	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat88	BRCA2.p.G1122E	Investigate Actionability	Biologically Relevant	2	MEL	Clinical evidence	Clinical evidence			Somatic variant	BRCA2
MEL-IPI_Pat88	BRD3.p.H474L		Biologically Relevant	1	MEL					Somatic variant	BRD3
MEL-IPI_Pat88	BRIP1.p.S913Y	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat88	BRIP1.p.S964F	Investigate Actionability		1	MEL			Inferential		Somatic variant	BRIP1
MEL-IPI_Pat88	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat88	CREBBP.p.P2383S		Biologically Relevant	1	MEL					Somatic variant	CREBBP
MEL-IPI_Pat88	CRKL.Amplification	Putatively Actionable		1	MEL		Clinical evidence			Somatic copy number	CRKL Amp
MEL-IPI_Pat88	EGFR.p.R932P	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline			Somatic variant	EGFR
MEL-IPI_Pat88	ERBB4.p.R124K		Biologically Relevant	1	MEL					Somatic variant	ERBB4
MEL-IPI_Pat88	ERG.Deletion	Biologically Relevant		1	MEL					Somatic copy number	ERG Del
MEL-IPI_Pat88	ESRP1.Splice_Site	Biologically Relevant		1	MEL					Somatic variant	ESRP1
MEL-IPI_Pat88	ESRP1.p.G476E	Biologically Relevant		1	MEL					Somatic variant	ESRP1
MEL-IPI_Pat88	FGFR1.p.A61V	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR1
MEL-IPI_Pat88	FGFR2.Deletion	Investigate Actionability		1	MEL	Preclinical				Somatic copy number	FGFR2 Del
MEL-IPI_Pat88	FGFR2.p.E712K	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat88	FIP1L1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	FIP1L1 Amp
MEL-IPI_Pat88	FLI1.Deletion	Biologically Relevant		1	MEL					Somatic copy number	FLI1 Del
MEL-IPI_Pat88	FLT3.p.G636E	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	FLT3
MEL-IPI_Pat88	GNAS.p.E122K		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat88	GNAS.p.Q111*		Biologically Relevant	1	MEL					Somatic variant	GNAS
MEL-IPI_Pat88	High Mutational Burden	Investigate Actionability		1	MEL	Clinical evidence				Tumor mutational burden	TMB
MEL-IPI_Pat88	KDR.p.R169K		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat88	KDR.p.R932K		Biologically Relevant	1	MEL					Somatic variant	KDR
MEL-IPI_Pat88	KIT.Amplification	Biologically Relevant		1	MEL					Somatic copy number	KIT Amp
MEL-IPI_Pat88	KIT.p.P573S	Investigate Actionability	Biologically Relevant	2	MEL	Guideline		Guideline		Somatic variant	KIT
MEL-IPI_Pat88	KIT.p.V559G	Putatively Actionable	Investigate Actionability	2	MEL	Guideline		Guideline		Somatic variant	KIT
MEL-IPI_Pat88	MDM4.p.S289F		Biologically Relevant	1	MEL					Somatic variant	MDM4
MEL-IPI_Pat88	MET.p.E221K	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical				Somatic variant	MET
MEL-IPI_Pat88	MTOR.p.S1863L	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	MTOR
MEL-IPI_Pat88	NF1.p.E602*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat88	NF1.p.L2298P	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	NF1
MEL-IPI_Pat88	OGDH--TET2	Biologically Relevant		1	MEL					Rearrangement	OGDH--TET2
MEL-IPI_Pat88	PBRM1.p.P385L	Investigate Actionability		1	MEL	Clinical evidence				Somatic variant	PBRM1
MEL-IPI_Pat88	PDGFRA.Amplification	Biologically Relevant		1	MEL					Somatic copy number	PDGFRA Amp
MEL-IPI_Pat88	PMS2.p.Q402*	Biologically Relevant		1	MEL					Somatic variant	PMS2
MEL-IPI_Pat88	POLD1.p.S699F	Investigate Actionability		1	MEL	Inferential		Clinical evidence		Somatic variant	POLD1
MEL-IPI_Pat88	POT1.p.D561N	Biologically Relevant		1	MEL					Somatic variant	POT1
MEL-IPI_Pat88	PRPF8.p.Q483*	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat88	PRPF8.p.S1928L	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	PRPF8
MEL-IPI_Pat88	PTPN11.p.P312LSplice_Site	Investigate Actionability		1	MEL			Guideline		Somatic variant	PTPN11
MEL-IPI_Pat88	RUNX1.p.G438S	Investigate Actionability	Biologically Relevant	2	MEL			Guideline		Somatic variant	RUNX1
MEL-IPI_Pat88	RUNX1T1.p.E444K	Biologically Relevant		1	MEL					Somatic variant	RUNX1T1
MEL-IPI_Pat88	SETBP1.p.E844K	Investigate Actionability		1	MEL			Guideline		Somatic variant	SETBP1
MEL-IPI_Pat88	TACC3.p.Q319*	Biologically Relevant		1	MEL					Somatic variant	TACC3
MEL-IPI_Pat88	TP53.p.P278L	Investigate Actionability	Investigate Actionability	2	MEL		Clinical evidence	Clinical evidence		Somatic variant	TP53
MEL-IPI_Pat88	TSC2.p.P436S	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved				Somatic variant	TSC2
MEL-IPI_Pat88	WT1.p.Q240*		Biologically Relevant	1	MEL					Somatic variant	WT1
MEL-IPI_Pat88	WT1.p.R222C		Biologically Relevant	1	MEL					Somatic variant	WT1
MEL-IPI_Pat88	WT1.p.R246Q		Biologically Relevant	1	MEL					Somatic variant	WT1
MEL-IPI_Pat88	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat90	BLM.p.P715S	Investigate Actionability		1	MEL			Clinical evidence		Somatic variant	BLM
MEL-IPI_Pat90	BRAF.p.V600E	Putatively Actionable	Putatively Actionable	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat90	COSMIC Signature 7	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 7
MEL-IPI_Pat90	KRAS.Amplification	Biologically Relevant		1	MEL					Somatic copy number	KRAS Amp
MEL-IPI_Pat90	MAP2K1.p.I111M	Investigate Actionability	Biologically Relevant	2	MEL	Preclinical	Clinical evidence			Somatic variant	MAP2K1
MEL-IPI_Pat90	MDM2.Amplification	Putatively Actionable	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	MDM2 Amp
MEL-IPI_Pat90	PALB2.p.P249S	Investigate Actionability		1	MEL	Clinical evidence		Inferential		Somatic variant	PALB2
MEL-IPI_Pat90	ROS1.p.A1774V	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	ROS1
MEL-IPI_Pat90	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MEL-IPI_Pat92	BRAF.p.D594Y	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat92	BRAF.p.E611*	Investigate Actionability	Biologically Relevant	2	MEL	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
MEL-IPI_Pat92	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat92	COSMIC Signature 18	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 18
MEL-IPI_Pat92	FBXW7.p.R658*	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical				Somatic variant	FBXW7
MEL-IPI_Pat92	FGFR2.p.R210*	Biologically Relevant	Biologically Relevant	2	MEL					Somatic variant	FGFR2
MEL-IPI_Pat92	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat98	COSMIC Signature 1	Biologically Relevant		1	MEL					Mutational signature	COSMIC Signature 1
MEL-IPI_Pat98	ESRP1.Amplification	Biologically Relevant		1	MEL					Somatic copy number	ESRP1 Amp
MEL-IPI_Pat98	FGFR1.Deletion	Investigate Actionability	Investigate Actionability	2	MEL	Preclinical				Somatic copy number	FGFR1 Del
MEL-IPI_Pat98	FLI1.p.R147H	Biologically Relevant		1	MEL					Somatic variant	FLI1
MEL-IPI_Pat98	GATA3.Deletion	Biologically Relevant		1	MEL					Somatic copy number	GATA3 Del
MEL-IPI_Pat98	NRAS.p.Q61K	Investigate Actionability	Putatively Actionable	2	MEL	Clinical evidence		Clinical evidence		Somatic variant	NRAS
MEL-IPI_Pat98	RET.Deletion	Biologically Relevant	Investigate Actionability	2	MEL					Somatic copy number	RET Del
MEL-IPI_Pat98	Whole genome doubling	Investigate Actionability		1	MEL			Inferential		Aneuploidy	WGD
MO_1008	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1008	ATM.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	ATM Del
MO_1008	ATM.p.R3047*	Investigate Actionability	Investigate Actionability	2	SU2C	Clinical trial				Somatic variant	ATM
MO_1008	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1008	JAK1--TMEM104	Biologically Relevant		1	SU2C					Rearrangement	JAK1--TMEM104
MO_1008	NTRK3.p.V542A	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	NTRK3
MO_1008	PTEN.p.R233*	Investigate Actionability	Putatively Actionable	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MO_1008	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1008	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1012	ABLIM1--AKT2	Biologically Relevant		1	SU2C					Rearrangement	ABLIM1--AKT2
MO_1012	AKT1--OR52J2P	Biologically Relevant		1	SU2C					Rearrangement	AKT1--OR52J2P
MO_1012	AKT2--VPS51	Biologically Relevant		1	SU2C					Rearrangement	AKT2--VPS51
MO_1012	ARID1A.p.S1851fs	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	ARID1A
MO_1012	AZI1--FLCN	Biologically Relevant		1	SU2C					Rearrangement	AZI1--FLCN
MO_1012	BCL6B--CCNE1	Biologically Relevant		1	SU2C					Rearrangement	BCL6B--CCNE1
MO_1012	BCOR--TMEM53	Biologically Relevant		1	SU2C					Rearrangement	BCOR--TMEM53
MO_1012	BRCA2.p.A392V	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
MO_1012	BRCA2.p.L3277P	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
MO_1012	C17orf53--AKT1	Biologically Relevant		1	SU2C					Rearrangement	C17orf53--AKT1
MO_1012	C8orf34--RUNX1T1	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	C8orf34--RUNX1T1
MO_1012	CCND1--MYLK	Investigate Actionability		1	SU2C	Inferential		Clinical evidence		Rearrangement	CCND1--MYLK
MO_1012	CCND1--PPP1R13L	Investigate Actionability		1	SU2C	Inferential		Clinical evidence		Rearrangement	CCND1--PPP1R13L
MO_1012	CCND3--CDKN1A	Investigate Actionability		1	SU2C	Inferential				Rearrangement	CCND3--CDKN1A
MO_1012	CCNE1.p.R95Q	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	CCNE1
MO_1012	CDH1.p.I651fs		Biologically Relevant	1	SU2C					Somatic variant	CDH1
MO_1012	CDKN1B.p.P94fs		Biologically Relevant	1	SU2C					Somatic variant	CDKN1B
MO_1012	CDKN2B--SCRT1	Biologically Relevant		1	SU2C					Rearrangement	CDKN2B--SCRT1
MO_1012	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
MO_1012	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1012	CREBZF--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	CREBZF--COL1A1
MO_1012	CTNNB1.p.T41A	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic variant	CTNNB1
MO_1012	CYP2D8P1--TSC2	Biologically Relevant		1	SU2C					Rearrangement	CYP2D8P1--TSC2
MO_1012	DMBT1--BRD4	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	DMBT1--BRD4
MO_1012	DNMT3A--MAG	Biologically Relevant		1	SU2C					Rearrangement	DNMT3A--MAG
MO_1012	ELP4--POLD1	Biologically Relevant		1	SU2C					Rearrangement	ELP4--POLD1
MO_1012	EMC1--ALK	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	EMC1--ALK
MO_1012	EPHA5.p.T856I		Investigate Actionability	1	SU2C					Somatic variant	EPHA5
MO_1012	ERG.p.P411fs	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	ERG
MO_1012	ESR1.p.T585fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	ESR1
MO_1012	FIP1L1--THG1L	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	FIP1L1--THG1L
MO_1012	FLCN.p.330_331SS>S	Investigate Actionability		1	SU2C	Clinical evidence				Somatic variant	FLCN
MO_1012	FLT3.p.R311W	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Clinical evidence			Somatic variant	FLT3
MO_1012	FLT4--BCOR	Biologically Relevant		1	SU2C					Rearrangement	FLT4--BCOR
MO_1012	FOSL1--SLC45A3	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	FOSL1--SLC45A3
MO_1012	FRMD6--POLE	Biologically Relevant		1	SU2C					Rearrangement	FRMD6--POLE
MO_1012	GNS--DNMT3A	Biologically Relevant		1	SU2C					Rearrangement	GNS--DNMT3A
MO_1012	HIC2--PDGFRB	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	HIC2--PDGFRB
MO_1012	High Mutational Burden	Investigate Actionability		1	SU2C	Guideline				Tumor mutational burden	TMB
MO_1012	IDH2--WISP2	Biologically Relevant		1	SU2C					Rearrangement	IDH2--WISP2
MO_1012	IL12RB1.p.P10S	Biologically Relevant		1	SU2C					Somatic variant	IL12RB1
MO_1012	JAK3--ADAMTS9-AS2	Biologically Relevant		1	SU2C					Rearrangement	JAK3--ADAMTS9-AS2
MO_1012	JAK3--ODF3L2	Biologically Relevant		1	SU2C					Rearrangement	JAK3--ODF3L2
MO_1012	KEAP1.p.A95V	Biologically Relevant		1	SU2C					Somatic variant	KEAP1
MO_1012	KIF13A--EML4	Investigate Actionability		1	SU2C	Guideline				Rearrangement	KIF13A--EML4
MO_1012	MAP2K2--BRPF3	Biologically Relevant		1	SU2C					Rearrangement	MAP2K2--BRPF3
MO_1012	MIR145--ERG	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	MIR145--ERG
MO_1012	MLH1.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	MLH1 Del
MO_1012	MSH2.p.T335P	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	MSH2
MO_1012	MTOR.p.R2134Q	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	MTOR
MO_1012	MUTYH--FIP1L1	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	MUTYH--FIP1L1
MO_1012	NF1.p.T1881S	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	NF1
MO_1012	NF1.p.T676fs	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	NF1
MO_1012	NTRK1--CHAF1B	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	NTRK1--CHAF1B
MO_1012	NTRK1--RP11-566K19.5	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	NTRK1--RP11-566K19.5
MO_1012	NTRK2--ACOX2	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	NTRK2--ACOX2
MO_1012	PDGFRA--NTF4	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	PDGFRA--NTF4
MO_1012	PIK3CA.p.E545A	Putatively Actionable	Putatively Actionable	2	SU2C	Preclinical		Clinical trial		Somatic variant	PIK3CA
MO_1012	PRDX6--TSC1	Biologically Relevant		1	SU2C					Rearrangement	PRDX6--TSC1
MO_1012	PRPF8--GMEB2	Biologically Relevant		1	SU2C					Rearrangement	PRPF8--GMEB2
MO_1012	PTCD3--PIK3CA	Biologically Relevant		1	SU2C					Rearrangement	PTCD3--PIK3CA
MO_1012	PTCH1.p.P1202fs		Biologically Relevant	1	SU2C					Somatic variant	PTCH1
MO_1012	RAD51D.p.R266C	Investigate Actionability		1	SU2C	Inferential		Inferential		Somatic variant	RAD51D
MO_1012	RAF1.p.N71D	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	RAF1
MO_1012	RB1.p.R467*	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic variant	RB1
MO_1012	RB1.p.V742fs	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	RB1
MO_1012	RET--DDX42	Investigate Actionability		1	SU2C	Clinical trial				Rearrangement	RET--DDX42
MO_1012	RFX6--BCR	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	RFX6--BCR
MO_1012	RP11-147N17.1--IL12RB1	Biologically Relevant		1	SU2C					Rearrangement	RP11-147N17.1--IL12RB1
MO_1012	RUNX1T1--SRMS	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	RUNX1T1--SRMS
MO_1012	RUNX1T1.p.A203T	Biologically Relevant		1	SU2C					Somatic variant	RUNX1T1
MO_1012	SAMD14--NTRK3	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	SAMD14--NTRK3
MO_1012	SDC3--ARID1A	Biologically Relevant		1	SU2C					Rearrangement	SDC3--ARID1A
MO_1012	SF3B1--SIX4	Biologically Relevant		1	SU2C					Rearrangement	SF3B1--SIX4
MO_1012	SH3TC1--CDK4	Biologically Relevant		1	SU2C					Rearrangement	SH3TC1--CDK4
MO_1012	SMARCA4--KIF7	Biologically Relevant		1	SU2C					Rearrangement	SMARCA4--KIF7
MO_1012	SNRNP48--DNMT3A	Biologically Relevant		1	SU2C					Rearrangement	SNRNP48--DNMT3A
MO_1012	SUMO2--AKT2	Biologically Relevant		1	SU2C					Rearrangement	SUMO2--AKT2
MO_1012	TEX19--GATA3	Biologically Relevant		1	SU2C					Rearrangement	TEX19--GATA3
MO_1012	TMEM130--MAP2K1	Biologically Relevant		1	SU2C					Rearrangement	TMEM130--MAP2K1
MO_1012	TSSC2--EGFR	Biologically Relevant		1	SU2C					Rearrangement	TSSC2--EGFR
MO_1012	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1013	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1013	ATM.p.F1236L	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	ATM
MO_1013	COL1A1.p.G566V	Biologically Relevant		1	SU2C					Somatic variant	COL1A1
MO_1013	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
MO_1013	FGFR3.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	FGFR3 Del
MO_1013	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
MO_1013	TP53.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TP53 Del
MO_1013	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1014	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1014	BCR.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BCR Amp
MO_1014	BRD4.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	BRD4 Del
MO_1014	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1014	CRKL.Amplification	Putatively Actionable		1	SU2C		Clinical evidence			Somatic copy number	CRKL Amp
MO_1014	FGFR1.Amplification	Putatively Actionable		1	SU2C	Preclinical				Somatic copy number	FGFR1 Amp
MO_1014	MAPK1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	MAPK1 Amp
MO_1014	RB1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	RB1 Del
MO_1014	TP53.p.R209fs	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
MO_1014	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1015	ABL1.p.V959M	Investigate Actionability	Biologically Relevant	2	SU2C		Guideline			Somatic variant	ABL1
MO_1015	AR--RPL14	Biologically Relevant		1	SU2C					Rearrangement	AR--RPL14
MO_1015	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1015	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1015	EML4.p.R572G	Biologically Relevant		1	SU2C					Somatic variant	EML4
MO_1015	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1015	TMPRSS2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TMPRSS2 Del
MO_1015	UFC1--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	UFC1--COL1A1
MO_1020	COSMIC Signature 5	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 5
MO_1020	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1020	TP53.p.V173L	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1040	AR.p.Q903H	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
MO_1040	AR.p.T878A	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
MO_1040	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1040	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1054	BRD2.p.R732*		Biologically Relevant	1	SU2C					Somatic variant	BRD2
MO_1054	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1054	TMPRSS2--ETV4	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ETV4
MO_1071	COSMIC Signature 24	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 24
MO_1071	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1071	GNA11.p.R338C		Biologically Relevant	1	SU2C					Somatic variant	GNA11
MO_1071	KIT.p.A621T	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved		Guideline		Somatic variant	KIT
MO_1071	LINC00993--TMPRSS2	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	LINC00993--TMPRSS2
MO_1071	PRPF8.p.C1626F	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	PRPF8
MO_1071	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1071	TP53.p.R273L	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1074	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
MO_1074	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1074	PDGFRA.p.G195R	Investigate Actionability	Biologically Relevant	2	SU2C	Guideline				Somatic variant	PDGFRA
MO_1074	PIK3CB.p.N553S	Investigate Actionability		1	SU2C	Preclinical				Somatic variant	PIK3CB
MO_1084	ACPP--PIK3CB	Biologically Relevant		1	SU2C					Rearrangement	ACPP--PIK3CB
MO_1084	APC.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	APC Del
MO_1084	AR.p.KLE388del	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
MO_1084	ATR.Amplification		Investigate Actionability	1	SU2C					Somatic copy number	ATR Amp
MO_1084	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1084	NOTCH2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NOTCH2 Del
MO_1084	PIK3CB.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	PIK3CB Amp
MO_1084	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1094	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1094	PTEN.Splice_Site	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MO_1094	TSC2.p.D1644N	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved				Somatic variant	TSC2
MO_1095	APC.p.E1554fs		Investigate Actionability	1	SU2C					Somatic variant	APC
MO_1095	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1095	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1095	DNMT3A.p.R97*	Investigate Actionability	Biologically Relevant	2	SU2C			Clinical evidence		Somatic variant	DNMT3A
MO_1095	PIK3CA.p.C901F	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical		Clinical trial		Somatic variant	PIK3CA
MO_1095	PIK3CB.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	PIK3CB Amp
MO_1095	PTEN.Deletion	Putatively Actionable		1	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1095	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1095	TP53.p.G266E	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1095	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1096	AKT1.p.E17K	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical				Somatic variant	AKT1
MO_1096	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1096	ARID1A.p.M1300I	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	ARID1A
MO_1096	ATM.p.Q2809fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial				Somatic variant	ATM
MO_1096	CD44--SLC45A3	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	CD44--SLC45A3
MO_1096	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1096	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
MO_1096	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1096	KEAP1--CCSAP	Biologically Relevant		1	SU2C					Rearrangement	KEAP1--CCSAP
MO_1114	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1114	AURKA.p.G173R	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	AURKA
MO_1114	CD274.Deletion	Investigate Actionability		1	SU2C	Inferential				Somatic copy number	CD274 Del
MO_1114	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1114	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
MO_1114	JAK2.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	JAK2 Del
MO_1114	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
MO_1114	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1114	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1118	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1118	PTEN.p.R130*	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
MO_1118	RB1--UBE3C	Biologically Relevant		1	SU2C					Rearrangement	RB1--UBE3C
MO_1118	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
MO_1118	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1118	TP53.p.C135W	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1124	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1124	COSMIC Signature 4	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 4
MO_1124	MDM4.Amplification		Investigate Actionability	1	SU2C					Somatic copy number	MDM4 Amp
MO_1124	NOTCH2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NOTCH2 Del
MO_1124	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1124	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
MO_1124	SLC45A3.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	SLC45A3 Amp
MO_1124	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1124	TP53.p.K382fs	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
MO_1128	APC.p.L1564fs		Biologically Relevant	1	SU2C					Somatic variant	APC
MO_1128	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1128	CCND1.Amplification	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
MO_1128	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1128	TP53.p.R282W	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1130	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1130	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1130	COSMIC Signature 24	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 24
MO_1130	MT-ND4--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	MT-ND4--COL1A1
MO_1161	AR--RPL14	Biologically Relevant		1	SU2C					Rearrangement	AR--RPL14
MO_1161	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1161	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1161	JAK1.p.P861fs	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	JAK1
MO_1161	PBRM1.p.V49M	Investigate Actionability		1	SU2C	Clinical evidence				Somatic variant	PBRM1
MO_1161	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1161	RBM10.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RBM10 Amp
MO_1162	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1162	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
MO_1162	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1162	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
MO_1162	RB1--UBE3C	Biologically Relevant		1	SU2C					Rearrangement	RB1--UBE3C
MO_1162	RUNX1T1.p.A471V	Biologically Relevant		1	SU2C					Somatic variant	RUNX1T1
MO_1162	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1162	WT1.p.G263VSplice_Site		Biologically Relevant	1	SU2C					Somatic variant	WT1
MO_1162	ZRSR2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ZRSR2 Amp
MO_1176	CCND2.p.Q249K		Biologically Relevant	1	SU2C					Somatic variant	CCND2
MO_1176	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
MO_1176	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1176	PALB2.p.V928M	Investigate Actionability		1	SU2C	Clinical evidence		Inferential		Somatic variant	PALB2
MO_1176	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1176	TP53.p.S90fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
MO_1179	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1179	ATM.p.R23*	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial				Somatic variant	ATM
MO_1179	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1179	TP53.p.R282W	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1179	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1179	XPO1.p.Y721D		Biologically Relevant	1	SU2C					Somatic variant	XPO1
MO_1184	AR.p.H875Y	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
MO_1184	BRCA2.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Clinical trial				Somatic copy number	BRCA2 Del
MO_1184	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
MO_1184	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1184	PDGFRB.p.VGLPLP722del	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	PDGFRB
MO_1184	TMPRSS2.p.D134Y	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	TMPRSS2
MO_1192	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1192	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1192	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
MO_1192	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1192	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1192	TP53.p.C242F	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1192	VHL.p.T105K		Biologically Relevant	1	SU2C					Somatic variant	VHL
MO_1202	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1202	AURKB.Deletion	Investigate Actionability		1	SU2C	Preclinical				Somatic copy number	AURKB Del
MO_1202	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1202	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1202	FLCN.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	FLCN Del
MO_1202	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
MO_1202	MIR17HG.Deletion	Putatively Actionable		1	SU2C	Preclinical	Preclinical			Somatic copy number	MIR17HG Del
MO_1202	PRPF8.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	PRPF8 Del
MO_1202	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1202	RB1.Deletion	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	RB1 Del
MO_1202	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1202	TP53.Deletion	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	TP53 Del
MO_1202	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1215	BRD2.p.N9D		Biologically Relevant	1	SU2C					Somatic variant	BRD2
MO_1215	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
MO_1215	EPHA5.p.D926E		Biologically Relevant	1	SU2C					Somatic variant	EPHA5
MO_1215	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1215	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
MO_1215	TP53.p.R333fs	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
MO_1215	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1219	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1219	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
MO_1221	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1232	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1232	ARAF.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ARAF Amp
MO_1232	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
MO_1232	ESR1.Deletion	Investigate Actionability		1	SU2C			Clinical evidence		Somatic copy number	ESR1 Del
MO_1232	KRAS.p.Q61H	Investigate Actionability	Putatively Actionable	2	SU2C	Clinical trial	Clinical trial	Clinical evidence		Somatic variant	KRAS
MO_1232	KRAS.p.Q61L	Investigate Actionability	Putatively Actionable	2	SU2C	Clinical trial	Clinical trial	Clinical evidence		Somatic variant	KRAS
MO_1232	MIR17HG.Deletion	Putatively Actionable		1	SU2C	Preclinical	Preclinical			Somatic copy number	MIR17HG Del
MO_1232	RBM10.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RBM10 Amp
MO_1232	ROS1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	ROS1 Del
MO_1232	TP53.p.H193D	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1232	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1241	APC.p.P1433fs		Biologically Relevant	1	SU2C					Somatic variant	APC
MO_1241	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1241	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1241	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1241	FLT3.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	FLT3 Del
MO_1241	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
MO_1241	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1241	TP53--AC007193.6	Biologically Relevant		1	SU2C					Rearrangement	TP53--AC007193.6
MO_1241	TP53.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TP53 Del
MO_1241	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1244	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1244	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1244	MAP2K1.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	MAP2K1 Del
MO_1244	MSH2.p.I222L	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	MSH2
MO_1244	RB1.p.K615fs	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	RB1
MO_1244	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1244	TP53.p.Q165*	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
MO_1249	CCND1.Amplification	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
MO_1249	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1249	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1249	ROS1.p.R118*	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	ROS1
MO_1249	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1249	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1262	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1262	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1262	CRKL.Deletion	Investigate Actionability		1	SU2C		Clinical evidence			Somatic copy number	CRKL Del
MO_1262	RAD51C.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	RAD51C Del
MO_1262	SMARCB1.p.T186R		Biologically Relevant	1	SU2C					Somatic variant	SMARCB1
MO_1262	TMPRSS2--ETV4	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ETV4
MO_1263	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1263	CDK4.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline				Somatic copy number	CDK4 Amp
MO_1263	MYC.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	MYC Amp
MO_1263	PIK3CB.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	PIK3CB Amp
MO_1263	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1263	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1277	AR--RPL14	Biologically Relevant		1	SU2C					Rearrangement	AR--RPL14
MO_1277	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1277	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1277	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
MO_1277	GNAS.p.R146H		Biologically Relevant	1	SU2C					Somatic variant	GNAS
MO_1277	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1277	TP53--CDC16	Biologically Relevant		1	SU2C					Rearrangement	TP53--CDC16
MO_1316	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1316	AR.p.L702H	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
MO_1316	ARAF.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ARAF Amp
MO_1316	BCOR.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BCOR Amp
MO_1316	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1316	FGFR1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	FGFR1 Del
MO_1316	RBM10.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RBM10 Amp
MO_1316	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1316	TMPRSS2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TMPRSS2 Del
MO_1316	ZRSR2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ZRSR2 Amp
MO_1336	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1336	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1336	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1337	APC.p.R1450*		Investigate Actionability	1	SU2C					Somatic variant	APC
MO_1337	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
MO_1337	CDKN2C.Deletion	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CDKN2C Del
MO_1337	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1337	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1337	NOTCH2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NOTCH2 Del
MO_1337	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1337	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
MO_1337	TP53.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	TP53 Del
MO_1339	CDKN1B.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	CDKN1B Del
MO_1339	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1339	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
MO_1339	ERG.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	ERG Del
MO_1339	ESRP1.p.D238Y	Biologically Relevant		1	SU2C					Somatic variant	ESRP1
MO_1339	ETV6.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	ETV6 Del
MO_1339	PMS2.p.RQ287fs	Biologically Relevant		1	SU2C					Somatic variant	PMS2
MO_1339	RUNX1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	RUNX1 Del
MO_1339	RUNX1T1.p.R473W	Biologically Relevant		1	SU2C					Somatic variant	RUNX1T1
MO_1339	TP53.p.H179R	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
MO_1339	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
MO_1410	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
MO_1410	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
MO_1410	MET.Splice_Site	Investigate Actionability	Investigate Actionability	2	SU2C	Guideline				Somatic variant	MET
MO_1410	PIK3CA.p.E545K	Putatively Actionable	Putatively Actionable	2	SU2C	Preclinical		Clinical trial		Somatic variant	PIK3CA
MO_1410	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
MO_1410	ROS1.p.E1509KSplice_Site	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	ROS1
MO_1410	TMPRSS2.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	TMPRSS2 Del
MO_1410	TP53.p.F212fs	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
MO_1410	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS01448-1115161	AR.p.T878A	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS01448-1115161	CCND1.Amplification	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
PROS01448-1115161	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-1115161	CTNNB1.p.K335I	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic variant	CTNNB1
PROS01448-1115161	ESR1.Deletion	Investigate Actionability		1	SU2C			Clinical evidence		Somatic copy number	ESR1 Del
PROS01448-1115161	ESRP1.p.P334A	Biologically Relevant		1	SU2C					Somatic variant	ESRP1
PROS01448-1115161	FGFR1.Deletion	Investigate Actionability		1	SU2C	Preclinical				Somatic copy number	FGFR1 Del
PROS01448-1115161	GATA3.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	GATA3 Del
PROS01448-1115161	IGF1R.p.V1200I		Biologically Relevant	1	SU2C					Somatic variant	IGF1R
PROS01448-1115161	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
PROS01448-1115183	COL3A1--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL3A1--COL1A1
PROS01448-1115183	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-1115183	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
PROS01448-1115183	MIR17HG.Deletion	Putatively Actionable		1	SU2C	Preclinical	Preclinical			Somatic copy number	MIR17HG Del
PROS01448-1115183	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
PROS01448-1115183	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS01448-1115183	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
PROS01448-1115183	TP53.p.Y126*	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
PROS01448-1115202	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS01448-1115202	CCND1.Amplification	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
PROS01448-1115202	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-1115202	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
PROS01448-1115202	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
PROS01448-1115202	PRPF8.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	PRPF8 Del
PROS01448-1115202	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS01448-1115244	AR.p.L702H	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS01448-1115244	BCOR.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BCOR Amp
PROS01448-1115244	BRCA2.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Clinical trial				Somatic copy number	BRCA2 Del
PROS01448-1115244	COL1A1--KLK3	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--KLK3
PROS01448-1115244	ZRSR2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ZRSR2 Amp
PROS01448-6115219	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS01448-6115219	AR.p.L702H	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS01448-6115219	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115219	ETV1.p.H82R		Biologically Relevant	1	SU2C					Somatic variant	ETV1
PROS01448-6115219	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
PROS01448-6115219	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS01448-6115219	TP53.p.P301fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
PROS01448-6115219	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS01448-6115224	APC.p.I2329V		Biologically Relevant	1	SU2C					Somatic variant	APC
PROS01448-6115224	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS01448-6115224	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115224	COSMIC Signature 5	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 5
PROS01448-6115224	PRPF8.p.W1827*	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	PRPF8
PROS01448-6115224	ROS1.p.P579L	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	ROS1
PROS01448-6115224	TET2.p.A277T	Investigate Actionability	Investigate Actionability	2	SU2C	Guideline				Somatic variant	TET2
PROS01448-6115224	TMPRSS2--ETV4	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ETV4
PROS01448-6115227	AR.p.L702H	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS01448-6115227	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115227	FBXW7.p.S86A	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	FBXW7
PROS01448-6115227	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS01448-6115233	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115233	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
PROS01448-6115233	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
PROS01448-6115233	FLCN.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	FLCN Amp
PROS01448-6115233	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS01448-6115233	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS01448-6115234	CCND3.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	CCND3 Del
PROS01448-6115234	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115234	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
PROS01448-6115234	FLT3.p.G617V	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Clinical evidence			Somatic variant	FLT3
PROS01448-6115234	JAK1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	JAK1 Del
PROS01448-6115234	PTEN.Deletion	Putatively Actionable		1	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS01448-6115234	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS01448-6115237	ALK.p.R753W	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Preclinical			Somatic variant	ALK
PROS01448-6115237	APC.p.R2326*		Biologically Relevant	1	SU2C					Somatic variant	APC
PROS01448-6115237	CCND1--NCAM1	Investigate Actionability		1	SU2C	Inferential		Clinical evidence		Rearrangement	CCND1--NCAM1
PROS01448-6115237	CCND1.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
PROS01448-6115237	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
PROS01448-6115237	ERG.p.R130C	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic variant	ERG
PROS01448-6115237	ERG.p.R374C	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	ERG
PROS01448-6115237	TP53.p.IR195fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
PROS01448-6115237	TP53.p.R213*	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
PROS01448-6115237	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS01448-6115242	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS01448-6115242	CCND1.Amplification	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
PROS01448-6115242	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115242	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
PROS01448-6115242	GATA3.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	GATA3 Del
PROS01448-6115242	PTEN.Deletion	Putatively Actionable		1	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS01448-6115242	RUNX1T1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RUNX1T1 Amp
PROS01448-6115242	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS01448-6115247	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS01448-6115247	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115247	COSMIC Signature 4	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 4
PROS01448-6115247	PDE9A--TMPRSS2	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	PDE9A--TMPRSS2
PROS01448-6115247	TMPRSS2.p.V396E	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	TMPRSS2
PROS01448-6115247	TMPRSS2.p.W176C	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	TMPRSS2
PROS01448-6115250	AR.p.L702H	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS01448-6115250	BRCA2.p.H2361fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
PROS01448-6115250	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115250	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
PROS01448-6115250	TPX2.Deletion	Investigate Actionability		1	SU2C			Preclinical		Somatic copy number	TPX2 Del
PROS01448-6115250	ZRSR2.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	ZRSR2 Del
PROS01448-6115251	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS01448-6115251	ATM.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	ATM Del
PROS01448-6115251	CDH1.p.Q673*		Biologically Relevant	1	SU2C					Somatic variant	CDH1
PROS01448-6115251	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS01448-6115251	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
PROS01448-6115251	EPHA5.Splice_Site		Investigate Actionability	1	SU2C					Somatic variant	EPHA5
PROS01448-6115251	KRAS.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	KRAS Del
PROS01448-6115251	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
PROS01448-6115251	TP53.p.I255F	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
PROS10448-1115153	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS10448-1115153	AR.p.Q58L	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS10448-1115153	BCOR.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BCOR Amp
PROS10448-1115153	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS10448-1115153	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
PROS10448-1115153	PIK3R1.p.R194Q		Biologically Relevant	1	SU2C					Somatic variant	PIK3R1
PROS10448-1115153	RBM10.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RBM10 Amp
PROS10448-1115153	TSC2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	TSC2 Amp
PROS10448-1115154	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS10448-1115154	ATM.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	ATM Del
PROS10448-1115154	ATM.p.LWLEN2490fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial				Somatic variant	ATM
PROS10448-1115154	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS10448-1115154	FGFR1.Amplification	Putatively Actionable		1	SU2C	Preclinical				Somatic copy number	FGFR1 Amp
PROS10448-1115154	MYC.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	MYC Amp
PROS10448-1115154	POT1.p.Q16L	Biologically Relevant		1	SU2C					Somatic variant	POT1
PROS10448-1115154	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
PROS10448-1115154	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS10448-1115156	CDKN2C.Deletion	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CDKN2C Del
PROS10448-1115156	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS10448-1115156	PDGFB.p.R216H	Biologically Relevant		1	SU2C					Somatic variant	PDGFB
PROS10448-1115156	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS10448-1115156	ROS1.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	ROS1 Del
PROS10448-1115156	TP53.Splice_Site	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
PROS10448-1115156	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS10448-1115157	ALK.Splice_Site	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical	Preclinical			Somatic variant	ALK
PROS10448-1115157	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS10448-1115157	CD274.Deletion	Investigate Actionability		1	SU2C	Inferential				Somatic copy number	CD274 Del
PROS10448-1115157	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS10448-1115157	JAK2.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	JAK2 Del
PROS10448-1115157	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS10448-1115157	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS12319B-SU2C-06115114	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS12319B-SU2C-06115114	AR.p.L702H	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS12319B-SU2C-06115114	BRCA2.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Clinical trial				Somatic copy number	BRCA2 Del
PROS12319B-SU2C-06115114	CDH1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	CDH1 Del
PROS12319B-SU2C-06115114	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS12319B-SU2C-06115114	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
PROS12319B-SU2C-06115114	CTNNB1.p.S45C	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic variant	CTNNB1
PROS12319B-SU2C-06115114	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
PROS12319B-SU2C-06115114	GNAQ.p.Y80*		Biologically Relevant	1	SU2C					Somatic variant	GNAQ
PROS12319B-SU2C-06115114	PIK3CB.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	PIK3CB Amp
PROS12319B-SU2C-06115114	RUNX1T1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RUNX1T1 Amp
PROS12319B-SU2C-06115114	TMPRSS2.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	TMPRSS2 Del
PROS12319B-SU2C-06115115	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS12319B-SU2C-06115115	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS12319B-SU2C-06115115	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
PROS12319B-SU2C-06115115	CREBBP.p.P988T		Biologically Relevant	1	SU2C					Somatic variant	CREBBP
PROS12319B-SU2C-06115115	FGFR1.Deletion	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical				Somatic copy number	FGFR1 Del
PROS12319B-SU2C-06115115	KEAP1.Deletion	Putatively Actionable		1	SU2C		Preclinical			Somatic copy number	KEAP1 Del
PROS12319B-SU2C-06115115	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
PROS12319B-SU2C-06115115	TMPRSS2--ETV4	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ETV4
PROS12319B-SU2C-06115115	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS12319B-SU2C-06115117	AR.p.T878A	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS12319B-SU2C-06115117	AR.p.T878S	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
PROS12319B-SU2C-06115117	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS12319B-SU2C-06115117	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
PROS12319B-SU2C-06115117	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
PROS12319B-SU2C-06115117	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS12319B-SU2C-06115118	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS12319B-SU2C-06115118	BRIP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BRIP1 Amp
PROS12319B-SU2C-06115118	CCNE1.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical				Somatic copy number	CCNE1 Amp
PROS12319B-SU2C-06115118	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS12319B-SU2C-06115118	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
PROS12319B-SU2C-06115118	IGF1R.p.N1057S		Biologically Relevant	1	SU2C					Somatic variant	IGF1R
PROS12319B-SU2C-06115118	SLC45A3--ETV1	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	SLC45A3--ETV1
PROS12319B-SU2C-06115118	TP53.p.G266R	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
PROS12319B-SU2C-06115118	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS12319B-SU2C-06115121	APC.p.V1894fs		Biologically Relevant	1	SU2C					Somatic variant	APC
PROS12319B-SU2C-06115121	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS12319B-SU2C-06115121	BCL2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	BCL2 Del
PROS12319B-SU2C-06115121	BCR.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	BCR Del
PROS12319B-SU2C-06115121	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS12319B-SU2C-06115121	CRKL.Deletion	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence			Somatic copy number	CRKL Del
PROS12319B-SU2C-06115121	EZH2.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	EZH2 Del
PROS12319B-SU2C-06115121	MAPK1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MAPK1 Del
PROS12319B-SU2C-06115121	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
PROS12319B-SU2C-06115121	TP53.p.C176F	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
PROS12319B-SU2C-06115121	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS12319B-SU2C-06115122	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
PROS12319B-SU2C-06115122	AR.p.Q58L	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
PROS12319B-SU2C-06115122	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
PROS12319B-SU2C-06115122	EPHA3.p.R512Q		Biologically Relevant	1	SU2C					Somatic variant	EPHA3
PROS12319B-SU2C-06115122	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
PROS12319B-SU2C-06115123	ARID1A.p.D322E	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	ARID1A
PROS12319B-SU2C-06115123	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
PROS12319B-SU2C-06115123	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9001	APC.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	APC Del
SC_9001	CDKN1B.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	CDKN1B Del
SC_9001	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9001	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9001	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9001	TP53.Splice_Site	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9001	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9003	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9003	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9003	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9003	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9003	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9003	TP53.p.K139*	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9003	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9005	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9005	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9005	STAG2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	STAG2 Amp
SC_9005	TP53.p.R248W	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9005	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9007	AR.p.H875Y	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9007	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9007	COSMIC Signature 5	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 5
SC_9007	GRHL2--FLI1	Investigate Actionability		1	SU2C			Clinical evidence		Rearrangement	GRHL2--FLI1
SC_9008	AKT2.p.V140A	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	AKT2
SC_9008	ALK.p.G159R	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Preclinical			Somatic variant	ALK
SC_9008	ALK.p.R1436C	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Preclinical			Somatic variant	ALK
SC_9008	APC.p.E1554fs		Investigate Actionability	1	SU2C					Somatic variant	APC
SC_9008	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9008	AR.p.T878A	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9008	BCR.p.G218S	Investigate Actionability		1	SU2C		Clinical evidence			Somatic variant	BCR
SC_9008	BRD3.p.P24fs		Biologically Relevant	1	SU2C					Somatic variant	BRD3
SC_9008	CCND2.Splice_Site		Investigate Actionability	1	SU2C					Somatic variant	CCND2
SC_9008	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9008	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9008	ERBB4.p.G240*		Biologically Relevant	1	SU2C					Somatic variant	ERBB4
SC_9008	ERCC2.p.R282W	Investigate Actionability		1	SU2C	Clinical evidence				Somatic variant	ERCC2
SC_9008	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
SC_9008	EZH2.p.N640fs	Investigate Actionability	Biologically Relevant	2	SU2C			Clinical evidence		Somatic variant	EZH2
SC_9008	FBXW7.p.S546L	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	FBXW7
SC_9008	High Mutational Burden	Investigate Actionability		1	SU2C	Guideline				Tumor mutational burden	TMB
SC_9008	JAK1.p.P430fs	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	JAK1
SC_9008	JAK1.p.R873H	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	JAK1
SC_9008	JAK1.p.Y368*	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	JAK1
SC_9008	KEAP1.p.G11R	Biologically Relevant		1	SU2C					Somatic variant	KEAP1
SC_9008	MET.p.K1378E	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	MET
SC_9008	MITF.p.K307fs		Biologically Relevant	1	SU2C					Somatic variant	MITF
SC_9008	MSH2.p.A789fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	MSH2
SC_9008	MSH6.p.R468H	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	MSH6
SC_9008	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
SC_9008	NKX2-1.p.G312S		Biologically Relevant	1	SU2C					Somatic variant	NKX2-1
SC_9008	NOTCH1.p.A1944T		Biologically Relevant	1	SU2C					Somatic variant	NOTCH1
SC_9008	NTRK1.p.T264M	Biologically Relevant		1	SU2C					Somatic variant	NTRK1
SC_9008	PALB2.p.R566H	Investigate Actionability		1	SU2C	Clinical evidence		Inferential		Somatic variant	PALB2
SC_9008	PBRM1.p.Y1009H	Investigate Actionability		1	SU2C	Clinical evidence				Somatic variant	PBRM1
SC_9008	PIK3CA.p.R38H	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical		Clinical trial		Somatic variant	PIK3CA
SC_9008	POLE.p.K1070N	Investigate Actionability		1	SU2C	Inferential		Clinical evidence		Somatic variant	POLE
SC_9008	POLE.p.Y801C	Investigate Actionability		1	SU2C	Inferential		Clinical evidence		Somatic variant	POLE
SC_9008	POLE2.p.D476N	Biologically Relevant		1	SU2C					Somatic variant	POLE2
SC_9008	PRPF8.p.E173del	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	PRPF8
SC_9008	PRPF8.p.Y1369N	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	PRPF8
SC_9008	PTEN.p.L265fs	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
SC_9008	RUNX1T1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RUNX1T1 Amp
SC_9008	TP53.p.R273C	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9008	TSC2.p.T1070M	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved				Somatic variant	TSC2
SC_9009	AKT2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	AKT2 Del
SC_9009	BRCA1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	BRCA1 Del
SC_9009	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9009	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9009	ETV4.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	ETV4 Del
SC_9009	NFKBIA.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NFKBIA Del
SC_9009	NKX2-1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NKX2-1 Del
SC_9009	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9009	TMPRSS2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TMPRSS2 Del
SC_9009	TP53.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TP53 Del
SC_9009	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9010	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9010	BARD1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BARD1 Amp
SC_9010	CD274.Deletion	Investigate Actionability		1	SU2C	Inferential				Somatic copy number	CD274 Del
SC_9010	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9010	ERBB4.Amplification		Investigate Actionability	1	SU2C					Somatic copy number	ERBB4 Amp
SC_9010	FGFR1.Amplification	Putatively Actionable		1	SU2C	Preclinical				Somatic copy number	FGFR1 Amp
SC_9010	IDH1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	IDH1 Amp
SC_9010	JAK2.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	JAK2 Del
SC_9010	TSC2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	TSC2 Amp
SC_9010	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9011	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9011	TMPRSS2--DGKG	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--DGKG
SC_9016	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9016	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9016	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9016	TP53.p.IRVEGNLRVEYLDDRNT195fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9016	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9017	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9017	ETV5.p.H322R		Biologically Relevant	1	SU2C					Somatic variant	ETV5
SC_9017	PIK3CA.Amplification	Putatively Actionable		1	SU2C	Clinical trial				Somatic copy number	PIK3CA Amp
SC_9017	PIK3CB.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	PIK3CB Amp
SC_9017	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9017	TP53.p.R248Q	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9017	TSC2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TSC2 Del
SC_9018	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9018	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9018	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9018	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9018	TP53.p.R213*	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9019	AKT1.p.E17K	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical				Somatic variant	AKT1
SC_9019	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9019	CTNNB1.p.S45F	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic variant	CTNNB1
SC_9019	TP53.p.APAPSWPL86fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9020	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9020	CCND1.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
SC_9020	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9020	ERG--TTLL7	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	ERG--TTLL7
SC_9020	NF2.p.R196G		Biologically Relevant	1	SU2C					Somatic variant	NF2
SC_9020	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9020	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9020	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9020	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9021	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9021	ATR.p.R215P		Biologically Relevant	1	SU2C					Somatic variant	ATR
SC_9021	BRCA2.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Clinical trial				Somatic copy number	BRCA2 Del
SC_9021	BRCA2.p.V484fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
SC_9021	CDKN2C.Deletion	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CDKN2C Del
SC_9021	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9021	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9021	EGFR.Amplification	Putatively Actionable		1	SU2C	Clinical evidence				Somatic copy number	EGFR Amp
SC_9021	ESR1.p.N290K	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	ESR1
SC_9021	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
SC_9021	PIK3R1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	PIK3R1 Del
SC_9021	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9021	TP53.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	TP53 Del
SC_9021	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9022	AR--PLA2G2A	Biologically Relevant		1	SU2C					Rearrangement	AR--PLA2G2A
SC_9022	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9022	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9022	PTCH1.p.L518fs		Biologically Relevant	1	SU2C					Somatic variant	PTCH1
SC_9022	PTEN.Splice_Site	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
SC_9022	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9022	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9023	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9023	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
SC_9023	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
SC_9023	NOTCH2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NOTCH2 Del
SC_9023	RUNX1T1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RUNX1T1 Amp
SC_9023	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9024	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9024	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9024	PTEN.Deletion	Putatively Actionable		1	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9024	TP53.p.R181H	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9026	TMPRSS2.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	TMPRSS2 Del
SC_9026	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9027	ABL1.p.A633S	Investigate Actionability	Biologically Relevant	2	SU2C		Guideline			Somatic variant	ABL1
SC_9027	ATM.p.Q1970*	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial				Somatic variant	ATM
SC_9027	BAP1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	BAP1 Del
SC_9027	BRCA2.p.K3083fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
SC_9027	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9027	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9027	GNAS.p.A478V		Biologically Relevant	1	SU2C					Somatic variant	GNAS
SC_9027	NFKBIA.p.L234del		Biologically Relevant	1	SU2C					Somatic variant	NFKBIA
SC_9027	PIK3CA.Amplification	Putatively Actionable		1	SU2C	Clinical trial				Somatic copy number	PIK3CA Amp
SC_9027	ROS1.p.*TV147fsSplice_Site	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	ROS1
SC_9027	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9028	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9028	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9028	EGFR.p.I735V	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved	Guideline			Somatic variant	EGFR
SC_9028	MSH6.p.S274C	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	MSH6
SC_9028	PIK3R1.Splice_Site		Investigate Actionability	1	SU2C					Somatic variant	PIK3R1
SC_9028	SMO.p.Y394C		Biologically Relevant	1	SU2C					Somatic variant	SMO
SC_9028	TP53.p.P278L	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9029	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9029	AR.p.A430S	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9029	ATM.p.Q2637*	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial				Somatic variant	ATM
SC_9029	AURKA.p.R220G	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	AURKA
SC_9029	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9029	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
SC_9029	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
SC_9029	RUNX1T1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RUNX1T1 Amp
SC_9030	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9030	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9030	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9031	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9031	TP53.p.A159D	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9031	TSC2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TSC2 Del
SC_9032	BRCA2.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Clinical trial				Somatic copy number	BRCA2 Del
SC_9032	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9032	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9032	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
SC_9032	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
SC_9032	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9032	ROS1.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	ROS1 Del
SC_9032	RUNX1T1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RUNX1T1 Amp
SC_9032	TP53.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	TP53 Del
SC_9032	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9032	XPO1.p.H704L		Biologically Relevant	1	SU2C					Somatic variant	XPO1
SC_9032	ZRSR2.p.Q56H	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	ZRSR2
SC_9034	COL1A1--CPE	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--CPE
SC_9034	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9035	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9035	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9035	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9035	EPHA5.p.R605W		Biologically Relevant	1	SU2C					Somatic variant	EPHA5
SC_9035	FGFR1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	FGFR1 Del
SC_9035	NF1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NF1 Del
SC_9035	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9035	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9035	TP53.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	TP53 Del
SC_9035	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9036	BRAF.p.Q456R	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved	Guideline	Guideline		Somatic variant	BRAF
SC_9036	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9036	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9036	KIT.p.I531L	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved		Guideline		Somatic variant	KIT
SC_9036	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9037	APC.p.S1545*		Investigate Actionability	1	SU2C					Somatic variant	APC
SC_9037	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9037	PIK3CA.p.N1044K	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical		Clinical trial		Somatic variant	PIK3CA
SC_9037	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9037	TP53.p.A276fs	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9038	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9038	BRCA2.p.C311fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
SC_9038	CCND1.Amplification	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
SC_9038	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9038	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9038	ERRFI1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	ERRFI1 Del
SC_9038	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
SC_9038	MAP2K2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	MAP2K2 Amp
SC_9038	MTOR.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MTOR Del
SC_9038	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
SC_9038	RB1.Deletion	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9038	SLC45A3.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	SLC45A3 Amp
SC_9039	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9039	BCOR.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BCOR Amp
SC_9039	CHEK1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	CHEK1 Del
SC_9039	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9039	FGFR2.Deletion	Investigate Actionability		1	SU2C	Preclinical				Somatic copy number	FGFR2 Del
SC_9039	NTRK3.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	NTRK3 Del
SC_9039	POT1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	POT1 Amp
SC_9039	RAF1.p.P63L	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	RAF1
SC_9039	RBM10.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RBM10 Amp
SC_9039	STAG2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	STAG2 Amp
SC_9039	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9039	ZRSR2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ZRSR2 Amp
SC_9043	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9043	TSC2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TSC2 Del
SC_9046	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9046	AR.p.L702H	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9046	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9046	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9046	NTRK3.p.P319L	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	NTRK3
SC_9046	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9046	TP53.p.R175H	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9046	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9047	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9047	ARAF.p.L569P	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	ARAF
SC_9047	BAP1.p.L429W		Biologically Relevant	1	SU2C					Somatic variant	BAP1
SC_9047	BRCA1.p.H270R	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved	Clinical evidence			Somatic variant	BRCA1
SC_9047	CHEK2.p.Q69R	Investigate Actionability		1	SU2C	Inferential		Inferential		Somatic variant	CHEK2
SC_9047	COL1A1.p.R763H	Biologically Relevant		1	SU2C					Somatic variant	COL1A1
SC_9047	COSMIC Signature 26	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 26
SC_9047	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9047	CREBBP.p.Q1908R		Biologically Relevant	1	SU2C					Somatic variant	CREBBP
SC_9047	CREBBP.p.Q2209P		Biologically Relevant	1	SU2C					Somatic variant	CREBBP
SC_9047	DDR2.p.M629V		Biologically Relevant	1	SU2C					Somatic variant	DDR2
SC_9047	EPHA5.p.R11H		Biologically Relevant	1	SU2C					Somatic variant	EPHA5
SC_9047	EWSR1.p.S458G	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	EWSR1
SC_9047	GNAS.p.A84E		Biologically Relevant	1	SU2C					Somatic variant	GNAS
SC_9047	High Mutational Burden	Investigate Actionability		1	SU2C	Guideline				Tumor mutational burden	TMB
SC_9047	MAPK1.p.T206I	Investigate Actionability		1	SU2C	Preclinical				Somatic variant	MAPK1
SC_9047	NF1.p.F1413V	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	NF1
SC_9047	NOTCH1.p.S2471L		Biologically Relevant	1	SU2C					Somatic variant	NOTCH1
SC_9047	PDGFRB.p.T494A	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	PDGFRB
SC_9047	ROS1.p.Y645H	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	ROS1
SC_9047	SETBP1.p.H1212Y	Investigate Actionability		1	SU2C			Guideline		Somatic variant	SETBP1
SC_9047	SYK.p.G33D		Biologically Relevant	1	SU2C					Somatic variant	SYK
SC_9047	ZRSR2.p.A310T	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	ZRSR2
SC_9048	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9048	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9048	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9048	CTNNB1.p.T41A	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic variant	CTNNB1
SC_9049	AURKA.p.P368S	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	AURKA
SC_9049	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9049	NFE2L2.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	NFE2L2 Del
SC_9049	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9049	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9050	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9050	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9050	EWSR1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	EWSR1 Del
SC_9050	GNAS.p.D320N		Biologically Relevant	1	SU2C					Somatic variant	GNAS
SC_9050	NF2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NF2 Del
SC_9050	NOTCH1.p.S2336N		Biologically Relevant	1	SU2C					Somatic variant	NOTCH1
SC_9050	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9050	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9054	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9054	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9054	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9054	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
SC_9054	MTOR.p.G2203S	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	MTOR
SC_9054	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9054	TP53.p.P322fs	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9054	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9055	AR--RPL14	Biologically Relevant		1	SU2C					Rearrangement	AR--RPL14
SC_9055	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9055	ATM.Deletion	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	ATM Del
SC_9055	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9055	FLI1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	FLI1 Del
SC_9055	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9056	AR.p.H875Y	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9056	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9056	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
SC_9056	PRPF8.p.R1151Q	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	PRPF8
SC_9056	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9057	BRCA2.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Clinical trial				Somatic copy number	BRCA2 Del
SC_9057	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9058	AR--PTMA	Biologically Relevant		1	SU2C					Rearrangement	AR--PTMA
SC_9058	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9058	AR.p.D297Y	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9058	COL1A1.p.R469Q	Biologically Relevant		1	SU2C					Somatic variant	COL1A1
SC_9058	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9058	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9058	CREBBP.p.S2356P		Biologically Relevant	1	SU2C					Somatic variant	CREBBP
SC_9058	CRKL.Deletion	Investigate Actionability		1	SU2C		Clinical evidence			Somatic copy number	CRKL Del
SC_9058	ETV1.p.Q9fs		Biologically Relevant	1	SU2C					Somatic variant	ETV1
SC_9058	GNAS.p.D108N		Biologically Relevant	1	SU2C					Somatic variant	GNAS
SC_9058	GOLGA4--RAF1	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	GOLGA4--RAF1
SC_9058	MAPK1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MAPK1 Del
SC_9058	MLH3.p.I185V	Investigate Actionability		1	SU2C	Clinical evidence				Somatic variant	MLH3
SC_9058	RUNX1.p.W248C	Investigate Actionability	Biologically Relevant	2	SU2C			Guideline		Somatic variant	RUNX1
SC_9058	SETBP1.p.R531M	Investigate Actionability		1	SU2C			Guideline		Somatic variant	SETBP1
SC_9058	SMARCA4.p.Y64*	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	SMARCA4
SC_9058	TP53.p.R282W	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9058	WT1.p.T146M		Biologically Relevant	1	SU2C					Somatic variant	WT1
SC_9058	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9059	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9059	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9059	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9059	FGFR1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	FGFR1 Del
SC_9059	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9059	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9059	TMPRSS2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TMPRSS2 Del
SC_9059	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9060	COSMIC Signature 5	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 5
SC_9060	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9060	PIK3CA.p.N114del	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved		Clinical trial		Somatic variant	PIK3CA
SC_9060	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9060	TP53.p.W146*	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9060	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9061	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9061	BRD4.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BRD4 Amp
SC_9061	CCNE1.Amplification	Putatively Actionable		1	SU2C	Preclinical				Somatic copy number	CCNE1 Amp
SC_9061	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9061	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9061	GNAS.p.P308L		Investigate Actionability	1	SU2C					Somatic variant	GNAS
SC_9061	MAP2K1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MAP2K1 Del
SC_9061	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9061	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9061	TP53.p.L206fs	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9061	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9062	ARAF.Amplification	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic copy number	ARAF Amp
SC_9062	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9062	EPHA5.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	EPHA5 Del
SC_9062	FGFR1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	FGFR1 Del
SC_9062	KDR.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	KDR Del
SC_9062	KIT.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	KIT Del
SC_9062	MTOR.p.R1482H	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	MTOR
SC_9062	PDGFRA.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	PDGFRA Del
SC_9062	PIK3R1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	PIK3R1 Del
SC_9062	PTEN.p.VL317fs	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
SC_9062	RB1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	RB1 Del
SC_9062	RBM10.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RBM10 Amp
SC_9062	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9063	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9063	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9063	ESR1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	ESR1 Del
SC_9063	PIK3CB.p.E1051K	Investigate Actionability		1	SU2C	Preclinical				Somatic variant	PIK3CB
SC_9063	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9063	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9063	TP53.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	TP53 Del
SC_9063	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9065	APC.p.E1554fs		Investigate Actionability	1	SU2C					Somatic variant	APC
SC_9065	AR.p.T878A	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9065	ASXL1.p.G643fs	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic variant	ASXL1
SC_9065	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9065	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9065	DDR2.p.L610P		Biologically Relevant	1	SU2C					Somatic variant	DDR2
SC_9066	AR.p.W742C	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9066	CDK5RAP2--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	CDK5RAP2--COL1A1
SC_9066	COL1A1--C1R	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--C1R
SC_9066	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9066	EZH2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	EZH2 Amp
SC_9066	NUDCD1--JAK1	Biologically Relevant		1	SU2C					Rearrangement	NUDCD1--JAK1
SC_9066	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9066	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9066	TP53.p.R175H	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9066	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9068	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9068	NOTCH2.p.C433Y		Biologically Relevant	1	SU2C					Somatic variant	NOTCH2
SC_9068	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9068	SLC45A3--ERG	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	SLC45A3--ERG
SC_9068	TP53.p.V272L	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9068	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9071	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9071	COL1A1--TEN1-CDK3	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--TEN1-CDK3
SC_9071	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9071	PIK3CB.p.E1051K	Investigate Actionability		1	SU2C	Preclinical				Somatic variant	PIK3CB
SC_9071	RDH11--AKT3	Biologically Relevant		1	SU2C					Rearrangement	RDH11--AKT3
SC_9071	TSC1.p.E1101fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	TSC1
SC_9071	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9072	AR--RPL14	Biologically Relevant		1	SU2C					Rearrangement	AR--RPL14
SC_9072	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9072	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9072	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9072	ERBB4.p.F862L		Biologically Relevant	1	SU2C					Somatic variant	ERBB4
SC_9072	FIP1L1.p.I211S	Biologically Relevant		1	SU2C					Somatic variant	FIP1L1
SC_9072	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9073	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9073	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9073	COSMIC Signature 20	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 20
SC_9073	COSMIC Signature 23	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 23
SC_9073	PTEN.p.F241S	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
SC_9073	TP53.p.Y220C	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9073	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9076	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9076	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9076	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9076	JAK1.p.R108W	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	JAK1
SC_9076	KIT.p.T84M	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved		Guideline		Somatic variant	KIT
SC_9076	NOTCH1.p.C1133Y		Biologically Relevant	1	SU2C					Somatic variant	NOTCH1
SC_9076	PTEN.p.DLDLTC22fsSplice_Site	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
SC_9076	RB1.Deletion	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9076	TPX2.p.E390V	Biologically Relevant		1	SU2C					Somatic variant	TPX2
SC_9076	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9076	XPO1.p.A795V		Biologically Relevant	1	SU2C					Somatic variant	XPO1
SC_9076	ZRSR2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ZRSR2 Amp
SC_9080	CDKN1B.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	CDKN1B Del
SC_9080	CHEK2.p.G385V	Investigate Actionability		1	SU2C	Inferential		Inferential		Somatic variant	CHEK2
SC_9080	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9080	PTEN.p.F238fs	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
SC_9080	ROS1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	ROS1 Del
SC_9081	APC.p.R653MSplice_Site		Biologically Relevant	1	SU2C					Somatic variant	APC
SC_9081	AR.p.H875Y	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9081	ASXL1.p.G643fs	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic variant	ASXL1
SC_9081	ASXL1.p.R499H	Investigate Actionability	Biologically Relevant	2	SU2C			Clinical evidence		Somatic variant	ASXL1
SC_9081	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9081	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9081	FLCN.p.G235S	Investigate Actionability		1	SU2C	Clinical evidence				Somatic variant	FLCN
SC_9081	GNAS.p.P459R		Biologically Relevant	1	SU2C					Somatic variant	GNAS
SC_9081	GNAS.p.R227H		Biologically Relevant	1	SU2C					Somatic variant	GNAS
SC_9081	High Mutational Burden	Investigate Actionability		1	SU2C	Guideline				Tumor mutational burden	TMB
SC_9081	MSH2.p.S676P	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	MSH2
SC_9081	NF1.p.Y628C	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	NF1
SC_9081	POLD1.p.G114fs	Investigate Actionability		1	SU2C	Inferential		Clinical evidence		Somatic variant	POLD1
SC_9081	RB1.p.R71fs	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	RB1
SC_9081	SF3B1.p.D907YSplice_Site	Investigate Actionability		1	SU2C			Guideline		Somatic variant	SF3B1
SC_9082	BRCA2.p.N2452fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
SC_9082	CDKN1B.p.KGAC96fs		Biologically Relevant	1	SU2C					Somatic variant	CDKN1B
SC_9082	COL1A1--SEC61A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--SEC61A1
SC_9082	COL1A1--SPARC	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--SPARC
SC_9082	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9082	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9082	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
SC_9082	FGFR1.Amplification	Putatively Actionable		1	SU2C	Preclinical				Somatic copy number	FGFR1 Amp
SC_9082	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
SC_9082	RUNX1T1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RUNX1T1 Amp
SC_9082	TP53.p.M246V	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9083	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9083	BRCA2.p.I870fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
SC_9083	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9083	EPHA5.p.P653L		Biologically Relevant	1	SU2C					Somatic variant	EPHA5
SC_9083	MT-CO3--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	MT-CO3--COL1A1
SC_9083	MT-ND2--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	MT-ND2--COL1A1
SC_9083	MT-ND3--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	MT-ND3--COL1A1
SC_9083	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
SC_9083	RPS2--AR	Biologically Relevant		1	SU2C					Rearrangement	RPS2--AR
SC_9083	TP53.p.R175H	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9083	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9084	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9084	BRCA2.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Clinical trial				Somatic copy number	BRCA2 Del
SC_9084	COSMIC Signature 5	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 5
SC_9084	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9084	KEAP1.p.Y300C	Biologically Relevant		1	SU2C					Somatic variant	KEAP1
SC_9084	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9084	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9084	TP53.p.P278A	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9084	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9086	COL1A1--LRP1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--LRP1
SC_9086	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9086	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
SC_9086	MT-RNR2--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	MT-RNR2--COL1A1
SC_9086	NTRK3.Splice_Site	Biologically Relevant	Investigate Actionability	2	SU2C					Somatic variant	NTRK3
SC_9086	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9086	TP53.p.G245S	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9089	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9089	ERCC2.p.R253C	Investigate Actionability		1	SU2C	Clinical evidence				Somatic variant	ERCC2
SC_9089	FGFR1.Deletion	Investigate Actionability		1	SU2C	Preclinical				Somatic copy number	FGFR1 Del
SC_9089	TMPRSS2.p.W384C	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	TMPRSS2
SC_9089	TP53.Deletion	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	TP53 Del
SC_9089	ZRSR2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ZRSR2 Amp
SC_9090	BRAF.Amplification	Putatively Actionable		1	SU2C		Clinical evidence			Somatic copy number	BRAF Amp
SC_9090	BRCA2.p.D1575Y	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
SC_9090	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
SC_9090	ETV6.p.S236L	Investigate Actionability	Biologically Relevant	2	SU2C			Clinical evidence		Somatic variant	ETV6
SC_9090	MYC.Amplification	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	MYC Amp
SC_9090	TP53.p.STPPPGTRVRAMAIYKQ149fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9090	TSC2.p.I606F	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved				Somatic variant	TSC2
SC_9090	WT1.p.G12R		Biologically Relevant	1	SU2C					Somatic variant	WT1
SC_9091	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9091	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9091	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9091	CTNNB1.p.S37C	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic variant	CTNNB1
SC_9091	ESRP1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ESRP1 Amp
SC_9091	RUNX1T1.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RUNX1T1 Amp
SC_9091	TP53.p.V122fs	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9092	AR--PLXNA1	Biologically Relevant		1	SU2C					Rearrangement	AR--PLXNA1
SC_9092	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9092	BRCA2.Deletion	Putatively Actionable		1	SU2C	Clinical trial				Somatic copy number	BRCA2 Del
SC_9092	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9092	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9092	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9092	RB1.Deletion	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9092	RUNX1T1.p.E250*	Biologically Relevant		1	SU2C					Somatic variant	RUNX1T1
SC_9092	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9092	TP53.p.R248Q	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9093	AR--ITM2B	Biologically Relevant		1	SU2C					Rearrangement	AR--ITM2B
SC_9093	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9093	AR.p.Q59L	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
SC_9093	BRAF--RNF38	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	BRAF--RNF38
SC_9093	CCND1.Amplification	Putatively Actionable		1	SU2C	Inferential		Clinical evidence		Somatic copy number	CCND1 Amp
SC_9093	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9093	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9093	ESRP1--PABPC1	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	ESRP1--PABPC1
SC_9093	EZH2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	EZH2 Amp
SC_9093	FIP1L1--FAAH	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	FIP1L1--FAAH
SC_9093	FLCN.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	FLCN Del
SC_9093	H19--AR	Biologically Relevant		1	SU2C					Rearrangement	H19--AR
SC_9093	KDM4B--RBM10	Biologically Relevant		1	SU2C					Rearrangement	KDM4B--RBM10
SC_9093	LRRC32--COL1A1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	LRRC32--COL1A1
SC_9093	LSM12--BRAF	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	LSM12--BRAF
SC_9093	MALAT1--CTNNB1	Biologically Relevant		1	SU2C					Rearrangement	MALAT1--CTNNB1
SC_9093	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
SC_9093	MET.p.T1307I	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	MET
SC_9093	MIR17HG.Deletion	Putatively Actionable		1	SU2C	Preclinical	Preclinical			Somatic copy number	MIR17HG Del
SC_9093	NAPB--BRD4	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	NAPB--BRD4
SC_9093	NDUFB6--FIP1L1	Investigate Actionability		1	SU2C	FDA-Approved				Rearrangement	NDUFB6--FIP1L1
SC_9093	PTMS--BRD4	Investigate Actionability		1	SU2C	Preclinical				Rearrangement	PTMS--BRD4
SC_9093	RNF13--ARID1A	Biologically Relevant		1	SU2C					Rearrangement	RNF13--ARID1A
SC_9093	SMARCA4--SLK	Biologically Relevant		1	SU2C					Rearrangement	SMARCA4--SLK
SC_9093	TM7SF3--BARD1	Biologically Relevant		1	SU2C					Rearrangement	TM7SF3--BARD1
SC_9093	TP53.p.CPHH176del	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
SC_9093	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9094	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9094	BRIP1.p.P198S	Investigate Actionability		1	SU2C			Inferential		Somatic variant	BRIP1
SC_9094	COL1A1--RP11-403P13.1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--RP11-403P13.1
SC_9094	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9094	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9094	ERBB3.p.S1237N	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	ERBB3
SC_9094	PTEN.p.YG155fs	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
SC_9096	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9096	BRD4.p.P1210L	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	BRD4
SC_9096	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9096	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9096	MSH6.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MSH6 Del
SC_9096	PDGFRB.p.R397W	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	PDGFRB
SC_9096	PTEN.Deletion	Putatively Actionable		1	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9096	PTEN.p.E235*	Investigate Actionability	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence	Clinical trial		Somatic variant	PTEN
SC_9096	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9096	TP53.p.Y220C	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9096	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9097	AR--RPL14	Biologically Relevant		1	SU2C					Rearrangement	AR--RPL14
SC_9097	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9097	BRCA2.p.L2155fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
SC_9097	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9097	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9097	JAK2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	JAK2 Del
SC_9097	MC1R.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MC1R Del
SC_9097	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9097	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9097	SF3B1.p.K1260N	Investigate Actionability		1	SU2C			Guideline		Somatic variant	SF3B1
SC_9097	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9097	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9099	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9099	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9099	FGFR1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	FGFR1 Del
SC_9099	SLC45A3--ERG	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Rearrangement	SLC45A3--ERG
SC_9099	TMPRSS2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TMPRSS2 Del
SC_9099	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9100	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9100	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9100	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9103	AKT3.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	AKT3 Del
SC_9103	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9103	AURKA.Amplification	Putatively Actionable		1	SU2C	Preclinical		Preclinical		Somatic copy number	AURKA Amp
SC_9103	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9103	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9103	EML4.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	EML4 Del
SC_9103	EPCAM.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	EPCAM Del
SC_9103	ETV6.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	ETV6 Del
SC_9103	FGFR3.p.R622H	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved				Somatic variant	FGFR3
SC_9103	GATA3.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	GATA3 Del
SC_9103	KRAS.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	KRAS Del
SC_9103	MLH1.p.R84W	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	MLH1
SC_9103	MSH2.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MSH2 Del
SC_9103	MSH6.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	MSH6 Del
SC_9103	RB1.Deletion	Putatively Actionable		1	SU2C			Clinical evidence		Somatic copy number	RB1 Del
SC_9103	ROS1.Deletion	Biologically Relevant		1	SU2C					Somatic copy number	ROS1 Del
SC_9103	STAG2.p.R298CSplice_Site	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	STAG2
SC_9104	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9104	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9104	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9104	ERBB3.p.R929W	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical evidence				Somatic variant	ERBB3
SC_9104	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9104	TP53.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	TP53 Del
SC_9107	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9107	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9107	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9107	PIK3CB.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	PIK3CB Amp
SC_9107	PIK3CB.p.R955*	Investigate Actionability		1	SU2C	Preclinical				Somatic variant	PIK3CB
SC_9107	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9107	TP53.p.K132T	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9107	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
SC_9109	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
SC_9109	ARID1A.p.S1534N	Investigate Actionability		1	SU2C	Preclinical		Clinical evidence		Somatic variant	ARID1A
SC_9109	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
SC_9109	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
SC_9109	DDR2.p.A345T		Biologically Relevant	1	SU2C					Somatic variant	DDR2
SC_9109	MCL1.p.Q221*		Biologically Relevant	1	SU2C					Somatic variant	MCL1
SC_9109	PIK3CB.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	PIK3CB Amp
SC_9109	PIK3R1.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	PIK3R1 Del
SC_9109	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
SC_9109	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
SC_9109	TP53.p.R273L	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
SC_9109	TSC2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TSC2 Del
SC_9109	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
TP_2001	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
TP_2001	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
TP_2001	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
TP_2001	ESR1.Deletion	Investigate Actionability	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	ESR1 Del
TP_2001	MITF.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	MITF Del
TP_2001	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
TP_2001	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
TP_2001	TP53.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	TP53 Del
TP_2001	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
TP_2009	BRCA2.p.SD884fs	Investigate Actionability	Biologically Relevant	2	SU2C	Clinical trial	Clinical evidence			Somatic variant	BRCA2
TP_2009	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
TP_2009	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
TP_2009	RB1.p.QATSAFQTQ631fs	Biologically Relevant	Biologically Relevant	2	SU2C					Somatic variant	RB1
TP_2010	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
TP_2010	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
TP_2010	IDH2.p.I61V	Investigate Actionability	Biologically Relevant	2	SU2C	FDA-Approved		Clinical evidence		Somatic variant	IDH2
TP_2010	TMPRSS2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	TMPRSS2 Del
TP_2010	TP53.p.G117fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
TP_2020	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
TP_2020	AR.p.Q58L	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
TP_2020	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
TP_2020	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
TP_2020	NOTCH1.p.G1215GSplice_Site		Biologically Relevant	1	SU2C					Somatic variant	NOTCH1
TP_2020	NOTCH2.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	NOTCH2 Del
TP_2032	AR.p.T878A	Putatively Actionable	Investigate Actionability	2	SU2C		Clinical evidence			Somatic variant	AR
TP_2032	COL1A1--MT-CO2	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--MT-CO2
TP_2032	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
TP_2032	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
TP_2034	AR.p.P893S	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
TP_2034	CDK6.p.R46W		Biologically Relevant	1	SU2C					Somatic variant	CDK6
TP_2034	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
TP_2034	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
TP_2054	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
TP_2054	TMPRSS2--ERG	Putatively Actionable		1	SU2C	Preclinical		Clinical evidence		Rearrangement	TMPRSS2--ERG
TP_2060	AR.p.W742C	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
TP_2060	COL1A1--BCL2L2-PABPN1	Investigate Actionability		1	SU2C	Guideline				Rearrangement	COL1A1--BCL2L2-PABPN1
TP_2060	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
TP_2060	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
TP_2060	PBRM1.p.R725G	Investigate Actionability		1	SU2C	Clinical evidence				Somatic variant	PBRM1
TP_2060	TP53.p.DRNTFRHSVVV208fs	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence	Clinical trial		Somatic variant	TP53
TP_2061	AR.Amplification	Putatively Actionable		1	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
TP_2061	AR.p.Y225D	Investigate Actionability	Biologically Relevant	2	SU2C		Clinical evidence			Somatic variant	AR
TP_2061	ARAF.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ARAF Amp
TP_2061	AURKB.Deletion	Investigate Actionability		1	SU2C	Preclinical				Somatic copy number	AURKB Del
TP_2061	BCOR.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	BCOR Amp
TP_2061	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
TP_2061	COSMIC Signature 3	Investigate Actionability		1	SU2C	Inferential				Mutational signature	COSMIC Signature 3
TP_2061	MAP2K4.Deletion		Investigate Actionability	1	SU2C					Somatic copy number	MAP2K4 Del
TP_2061	PIK3CA.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Clinical trial				Somatic copy number	PIK3CA Amp
TP_2061	PTEN.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C	Preclinical	Clinical evidence			Somatic copy number	PTEN Del
TP_2061	RB1.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	RB1 Del
TP_2061	RBM10.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	RBM10 Amp
TP_2061	SMARCA4.p.G231S	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	SMARCA4
TP_2061	TBL1XR1--PIK3CA	Biologically Relevant		1	SU2C					Rearrangement	TBL1XR1--PIK3CA
TP_2061	TP53.Deletion	Putatively Actionable	Investigate Actionability	2	SU2C			Clinical evidence		Somatic copy number	TP53 Del
TP_2061	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
TP_2061	ZRSR2.Amplification	Biologically Relevant		1	SU2C					Somatic copy number	ZRSR2 Amp
TP_2064	AR.Amplification	Putatively Actionable	Investigate Actionability	2	SU2C	Guideline	Guideline			Somatic copy number	AR Amp
TP_2064	AURKA.Amplification	Putatively Actionable		1	SU2C	Preclinical		Preclinical		Somatic copy number	AURKA Amp
TP_2064	BLM.p.V54I	Investigate Actionability		1	SU2C			Clinical evidence		Somatic variant	BLM
TP_2064	COSMIC Signature 1	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 1
TP_2064	COSMIC Signature 15	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 15
TP_2064	COSMIC Signature 6	Biologically Relevant		1	SU2C					Mutational signature	COSMIC Signature 6
TP_2064	MPL.p.A134T	Investigate Actionability	Biologically Relevant	2	SU2C	Preclinical				Somatic variant	MPL
TP_2064	TP53.p.H179R	Investigate Actionability	Investigate Actionability	2	SU2C		Clinical evidence	Clinical evidence		Somatic variant	TP53
TP_2064	Whole genome doubling	Investigate Actionability		1	SU2C			Inferential		Aneuploidy	WGD
